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Study Objectives 
Chlamydia suis is considered to be endemic in commercial pigs and causes important 
economic losses in pig production (Schautteet and Vanrompay 2011a). Its primary 
pathogenicity is proven by several experimental infections in gnotobiotic pigs (Rogers et al. 
1996;|Rogers et al. 1996}; Rogers and Andersen 1999, 2000; Reinhold et al. 2. 2009b; 
Pospischil et al. 2009b; Reinhold et al. 2010). Porcine chlamydial infections are not always 
associated with clinical symptoms, but if so, they lead to important economical losses due to 
arthritis, pericarditis, polyserositis, pneumonia, conjunctivitis, enteritis, diarrhea and 
reproductive failure (Willigan and Beamer 1955; Sarma et al. 1983; Woollen et al. 1990; 
Zahn et al. 1995; Andersen and Rogers 1998; Eggemann et al. 2000). Chlamydiae are 
generally highly sensitive to the relatively inexpensive Tc antibiotics. However, tetracycline 
resistant (Tc
R
) Chlamydia suis strains have been appearing in the U.S. and European pig 
industry (Andersen and Rogers 1998; Di Francesco et al. 2008; Borel et al. 2012; Schautteet 
et al. 2013). The use of Tc antibiotics as treatment of chlamydial infections in pigs, leads to 
selection for resistant strains (Borel et al. 2012). Consequently, the emergence of Tc
R
 strains 
requires treatment with other, more expensive antibiotics and, may become economically 
devastating to pig production. Besides the economical consequences, Tc
R
 Chlamydia suis 
strains pose an additional risk for human health. Chlamydia suis is phylogenetically closely 
related to the human pathogenic species Chlamydia trachomatis (Everett et al. 1999b) and is, 
for this reason, believed to be a zoonotic bacteria. If zoonotic transmission really occurs, 
human patients may be co-infected with Tc
R
 Chlamydia suis and Tc
S
 Chlamydia trachomatis 
bacteria, providing the ideal environment for transfer of the resistance gene. Tetracycline 
treatment of these patients will even further enchance the emergence and spread of Tc
R
 
Chlamydia trachomatis strains, endangering the treatment of millions of people worldwide 
(Mabey 2008; WHO 2008). Monitoring the spread of Tc
R
 Chlamydia suis into commercial 
pigs and the zoonotic transmission to humans is therefore needed to assess the associated risk 
and to decide on the appropriate measures. For this purpose, reliable Chlamydia suis-specific 
molecular and serological tests to detect Chlamydia suis bacteria in animal and human 
specimen, are indispensable. Although several efforts have been made during the last 15 
years, a reliable molecular diagnostic test, able to specifically detect Chlamydia suis in both 
animal and human samples was unavailable. Therefore, the first aim of this thesis was the 
development of a sensitive and specific Chlamydia suis real-time PCR to examine clinical 
samples of both pigs and humans, suitable to be applied on a large scale basis. We targeted 
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the 23S rRNA gene for its highly discriminatory sequences and used a labeled probe to further 
improve species specificity.  
Although the zoonotic potential of Chlamydia suis is likely, no former studies addressed the 
transmission risk to humans in close contact with pigs. Therefore, the second aim of this 
thesis was to examine zoonotic transmission of Chlamydia suis in a pig slaughterhouse, 
considered to be a risk environment for transfer. Animals, slaughterhouse employees, air and 
potentially contaminated contact surfaces were sampled and diagnosed for Tc
R
 
Chlamydia suis. Additionally, the human volunteers were examined for 
Chlamydia trachomatis, to detect co-infections, and questioned for the appearance of clinical 
symptoms.  
 
Although DNA-based methods can provide fast detection of viable C. suis bacteria in animal 
or human samples, the presence of these specimens might still be the result of contamination. 
In contrast to nucleic acid amplification assays, serological tests to detect the presence of anti-
C. suis antibodies are able to actually prove the presence of an immunological response and 
thus an infection. Unfortunately, at present, no assay for C. suis specific serodiagnosis is 
available. Therefore, the third aim of this thesis was the identification of an antigenic and 
C. suis specific peptide epitope for a serological test using three candidate proteins, selected 
based on a literature overview of the knowledge obtained from other species. 
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1. Introduction 
Members of the family of the Chlamydiaceae are obligate intracellular pathogens that cause a 
broad range of diseases in man, other mammals and birds. Chlamydia (C.) trachomatis and 
C. pneumoniae are the most established species in humans. Chlamydia trachomatis is the 
leading cause of infectious blindness and sexually transmitted disease and is believed to be 
linked to cardiovascular disease (Schachter 1999). Chlamydia pneumoniae is responsible for 
ten percent of the pneumonia and five percent of bronchitis and sinusitis cases in adults. 
Moreover, chronic infection could contribute to atherosclerosis (Belland et al. 2004; 
Campbell and Kuo 2004). The most common chlamydial species infecting animals are C. suis 
(pigs), C. abortus (sheep and goats), C. psittaci (birds) and C. pecorum (mammals). These 
infections can result in conjunctivitis, cardiovascular or systemic disease, abortion, infertility, 
enteritis, encephalitis, arthritis or respiratory disease (Everett 2000; Longbottom and Coulter 
2003).  
2. History 
Jacob Ritter was the first to link multiple cases of pneumonia to the prior exposure of the 
patients to tropical pet birds in Switzerland (Ritter 1880). After a new outbreak in Paris three 
years later, the disease was named ‘psittacosis’, after ‘psittakos’ the Greek word for parrot, 
since these animals were the source of infection (Morange 1895). Several pandemic outbrakes 
of human psittacosis occurred between 1929 and 1930. The first chlamydial infections in 
domestic mammals were described in 1936 subsequent to abortions in sheep in Schotland 
although at the time, the abortions were considered to be the result of environmental factors 
(Greig 1936). Only in 1950, it was demonstrated that these abortions were the result of an 
infectious disease caused by an organism of the psittacosis group (Stamp et al. 1950). 
Chamydial organisms were described for the first time by Halberstaedter & von Prowazek in 
1907 when they described intracytoplasmatic inclusions containing large numbers of micro-
organisms in human conjuncitval epithelial cells derived from human patients with trachoma, 
and from orang-utans inoculated with material from trachoma cases. Considered to be 
protozoa, those micro-organisms were named ‘Chlamydozoa’ after the Greek word ‘Chlamys’ 
for mantle. In 1930, Bedson & Western isolated small basophile particles from blood and 
tissues of infected birds and humans during an outbreak of human psittacosis. That same year, 
the causative agent of Lymphogranuloma venereum (LGV) was isolated from human tissue 
(Hellerström and Wassén 1930). Since these particles were not restrained by bacterial filters 
6   Chapter I 
 
and could not be cultured on artificial media, they were classified as viruses in the psittacosis-
LGV group. Two years later, the complicated developmental cycle was described for the first 
time when Bedson and Bland (1932) identified the reticulate body, additionally to the 
previously described elementary body. Still, these pathogens were considered to be viruses 
because of their obligate intracellular life style. Because of their multiplication through binary 
fission, Bedson & Gostling (1954) considered these ‘obligate intracellular parasites with 
bacterial affinities’ more related to Rickettsiae than to bacteria. The development of electron 
microscopy and cell culture (1965) facilitated the clarification of the true nature of these 
pathogens. Because of their distinct developmental cycle, the presence of both DNA and 
RNA, the structure of the cell wall and their sensitivity for antibiotics, the Chlamydiaceae 
were finally classified as Gram-negative bacteria (Moulder 1966).  
3. Taxonomy 
Till 1999, the order of the Chlamydiales contained one family, the Chlamydiaceae, with only 
one genus, Chlamydia, consisting of four species, Chlamydia (C.) trachomatis, C. psittaci, 
C. pneumoniae and C pecorum. Everett et al. (1999a) proposed a new classification based on 
phylogenetic analyses of the 16S and 23S ribosomal RNA (rRNA) genes and genetical, 
morphological and phenotypical information (Figure I-1). The family of the Chlamydiaceae 
were divided into two genera, Chlamydia and Chlamydophila, comprising nine species. The 
genus Chlamydia contained Chlamydia (C.) muridarum, C. suis and C. trachomatis. The 
genus Chlamydophila comprised Chlamydophila (Cp.) psittaci, Cp. pecorum and 
Cp. pneumoniae. Additionally, three new Chlamydophila species were derived from 
Cp. psittaci, namely Cp. abortus, Cp. caviae and Cp. felis (Everett et al. 1999a). Moreover, 
the order of the Chlamydiales was expanded with three additional families 
(Parachlamydiaceae, Simkaniaceae, Waddliaceae).  
Chlamydial infection biology 7 
 
 
Figure I- 1 Phylogenetic classification of the order Chlamydiales as proposed by Everett et al. (1999a). 
Trees were constructed using full-length 23S rRNA genes. Branch lengths are measured in nucleotide 
substitutions and the numbers represent the percentage of time each branch was found in 1000 bootstrap 
replicates (no value shown if <50%).  
 
All organisms within the order Chlamydiales are Gram-negative, obligate intracellular 
bacteria with a unique biphasic developmental cycle of replication, sharing more than 80% of 
16S and 23S rRNA sequence identity (Everett et al. 1999a). Phylogenetic analysis based on 
the ompA gene, the groEL chaperonin, small and large (60-kDa) cysteine-rich lipoprotein and 
the KDO transferase, confirmed the separation in two genera (Bush and Everett 2001). Since 
the introduction of the classification, the order of the Chlamydiales was further expanded with 
four new families of Chlamydia-like bacteria (Piscichlamydiaceae, Clavochlamydiaceae, 
Rabdochlamydiaceae and Criblamydiaceae) (Horn 2008). These families will not be 
discussed further.  
Although the new classification generally seems relevant in terms of host range, disease 
symptoms and virulence, and provides easy tools for identifying new strains, the separation of 
the Chlamydiaceae family into the genera Chlamydia and Chlamydophila was controversial 
(Everett and Andersen 2001; Schachter et al. 2001). In 2010, the taxonomy has changed again 
and all nine species now belong to the single genus of Chlamydia (Table I-1) (Greub 2010a, 
2010b). Recently, Sachse et al. proposed the addition of two new species to the current 
classification: Chlamydia avium sp. nov. comprising strains from pigeons and psittacine birds 
and Chlamydia gallinacea sp. nov. comprising strains from poultry. Evidence for the 
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existence for two new members of the family Chlamydiaceae was obtained from phylogenetic 
analysis of ribosomal RNA and ompA genes, as well as multi-locus sequence analysis (Sachse 
et al. 2014). Figure I-2 shows the phylogenetic classification of the Chlamydiaceae, including 
the two new species, based on almost complete 16S rRNA sequences.  
 
Table I- 1 Members of the family Chlamydiaceae [according to Greub (Greub 2010a, 2010b). Adapted from 
Kerr et al. (2005) 
Species Host Clinical signs 
Chlamydia trachomatis Humans 
Chronic conjunctivitis and blindness (trachoma) 
Sexually transmitted disease (STD) 
Infection of the urogenital tract, infertility 
   
Chlamydia muridarum 
Mice 
Hamsters 
Respiratory tract infection 
Genital tract infection 
   
Chlamydia suis
 b
 Pigs 
Diarrhea, pneumonia, conjunctivitis, reproductive 
disorders 
   
Chlamydia pneumoniae 
Humans 
Koala 
Pneumonia, bronchitis, encephalomyelitis, laryngitis, 
atherosclerosis, reactive arthritis  
   
Chlamydia psittaci
 a
 Birds Respiratory tract infection 
   
Chlamydia gallinaceae
b
 
Chicken 
Guinea fowl 
Turkey 
Respiratory tract infection 
   
Chlamydia avium
b
 
Pigeons 
Psittacine birds 
Respiratory tract infection 
   
Chlamydia abortus
 a
 
Ruminants 
Pigs 
Reproductive disorders, abortion and bad semen 
quality 
   
Chlamydia pecorum 
Ruminants  
Pigs 
Koala 
Reproductive disorders, infertility, infection of the 
urine tract (koala) and abortion, enteritis, polyarthritis, 
encephomyelitis, metritis, conjunctivitis and 
pneumonia (other animals) 
   
Chlamydia felis
 b
 Cats Conjunctivitis and respiratory tract infection 
   
Chlamydia caviae
 b 
Guinea pigs Ocular and urogenital tract infection 
a 
Zoonotic pathogen  
b
 Potential Zoonotic pathogen  
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Figure I- 2 Phylogenetic reconstruction of the Chlamydiaceae classification, including the two new species 
C. avium and C. gallinaceae based on the alignment of almost complete 16S rRNA genes. The numbers on 
the nodes indicate the bootstrap support of each branch after 100 replicates. The bar indicates 1% sequence 
divergence. Adapted from Sachse et al. (2014)  
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4. Developmental cycle 
Chlamydiaceae are obligate intracellular bacteria and are completely depending on host 
epithelial cells for their intracellular survival and growth. Therefore, Chlamydiaceae have a 
unique biphasic replication characterized by two distinct morphological forms (Figure I-3). 
The infectious elementary bodies (EBs) are small, 0.2 to 0.3 µm electron dense structures 
adapted to survive up to several months in the hostile extracellular environment (Longbottom 
and Coulter 2003). Upon internalization in cytoplasmatic inclusions, EBs transform to the 
metabolically active form, called reticulate bodies (RBs), and replicate by binary fission. RBs 
have a diameter of 0.5 to 1.6 µm and are non-infectious (Newhall and Jones 1983; Ward 
1988).  
 
 
 
Figure I-3 Schematic representation of the developmental cycle of the Chlamydiaceae. Numbers refer to 
hours post infection or inoculation, though the timing of the different stages in the cycle varies depending on the 
chlamydial species and the host cell (Geens 2005).  
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Attachment of the EB to the eukaryotic cell surface forms the start of the acute infection. 
Binding preferentially occurs at surface microvilli. Since the base of the microvilli are areas 
of active transport of extracellular materials into the host cells, attachment to these sites might 
enable a rapid and efficient entry (Escalante-Ochoa et al. 1998). Upon binding, EBs are 
internalized in tight, endocytic vesicles, called inclusions. There is currently no general 
convention on the mechanism of attachment and entry since several conflicting mechanisms 
have been described, including receptor-mediated endocytosis in clathrin-coated pits (Wyrick 
et al. 1989), pinocytosis in non-clathrin-coated pits (Prain and Pearce 1989) and 
microfilament dependent phagocytosis (Byrne & Moulder, 1978; Ward & Murray, 1984). The 
newly formed inclusions efficiently escape fusion with cellular lysosomes and EBs start to 
differentiate into RBs two hours post infection. These RBs move towards the periphery of the 
inclusion and start replication from 8 h post infection on. Active replication through binary 
fission continues until RBs detach from the inclusion membrane and consequently revert into 
EBs again. EBs are stored in the lumen of the inclusion until they are released from the host 
cell at 48 to 72 h post infection through lysis or reversed endocytosis. The exact length of the 
developmental cycle is species dependent.  
During maturation from RBs to EBs, morphologically intermediate bodies (IBs) can be 
observed in the host cell. These IBs have a diameter of 0.3 to 1.0 µm and are able to infect 
host cells in vitro (Litwin et al. 1961; Costerton et al. 1976; Vanrompay et al. 1996). 
Alternatively, the normal developmental cycle can be interrupted and bacteria survive in an 
atypical, intracellular and metabolically less active state inside the host cell. This form of 
chronic infection is known as persistence and can be induced by nutritional deficiencies, 
antibiotic pressure, cytokines and environmental changes due to hormonal fluctuations. Thus, 
bacteria residing inside the host cell are partially protected from host-defense mechanisms and 
antibiotic therapy (Mpiga and Ravaoarinoro 2006). Once the inducing factor is removed, 
persistent bodies revert to normal RBs and generate infectious EBs. 
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5. Chlamydial effector proteins  
Members of the Chlamydiales encode a Type III secretion system (T3SS) (Hsia et al. 1997). 
This efficient molecular syringe is essential for its entrance, growth and survival in eukaryotic 
host cells through transport of effector proteins to the host cell cytoplasm. The number of 
secreted anti-host proteins is estimated at 80 for C. trachomatis (Betts et al. 2009), although 
the exact function of many proteins remains to be uncovered. Within minutes upon 
attachment of EBs, the T3SS translocates already produced effector proteins to the host 
cytoplasm, including Tarp for Translocated Actin-Recruiting Phosphoprotein. This protein is 
spatially and temporarily associated with the recruitment of actin at the site of internalization 
(Clifton et al. 2004). The formation of an actin-rich pedestal underneath the attachment site 
eventually leads to the uptake of EBs into membrane-bound vesicles (Carabeo et al. 2002; 
Coombes and Mahony 2002; Subtil et al. 2004; Beeckman et al. 2007). The Tarp-mediated 
actin polymerization is not simply the result of a stable association between Tarp and actin but 
is more complex, involving multiple domains of Tarp (Jewett et al. 2006). 
 
6. The Chlamydial Outer Membrane Complex (COMC) 
Like all Gram-negative bacteria, Chlamydiaceae are surrounded by an outer membrane (OM) 
and a cytoplasmatic inner membrane (IM), separated by a periplasmic space (Figure I-4). The 
EB outer membrane contains phopholipids, lipids, lipopolysaccharides (LPS) and proteins. 
The strength of the Gram-negative cell wall is usually provided by peptidoglycan, covalently 
bound to lipoproteins. Typically, this part of the membrane is insoluble in sarkosyl, an ionic 
detergent. The Chlamydiaceae cell wall contains only a small amount of structural 
peptidoglycan, but, derives its strength from crosslinks formed between the sulphur atoms of 
sulphur amino acid rich proteins in the outer envelope (Moulder 1993; Hatch 1996). Still, a 
part of their cell wall is also insoluble in sarkosyl and this fraction is called the ‘Chlamydia 
Outer Membrane Complex’ (COMC). This protein complex predominantly consists of 
MOMP, two cystein rich proteins (CRP), EnvA or OmcA and EnvB or OmcB, and the 
polymorphic membrane proteins (Pmps) (Hatch et al. 1984; Sardinia et al. 1988; Stephens 
and Lammel 2001). Besides, the outer membrane also contains the proteins PorB, Omp85, 
OprB, heat shock proteins hsp60 and hsp70, CTL 0541, CTL0648, CTL0887 and Pal. The 
proteins of major importance will be discussed in more detail.  
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Figure I-4 Schematic representation of the chlamydial EB double membrane. In the outer membrane, 
MOMP, both CRP and the Pmps are represented. Adapted from Hatch (1996). 
 
The Major Outer Membrane Protein (MOMP) is a cystein-rich protein with a molecular 
weight of approximately 40 kDa. About 60% of the EB outer membrane and almost 100% of 
the RB is covered by MOMP (Hatch and McClarty 1998). This protein is important for the 
maintenance of the structural rigidity of the EB and functions as an adhesion, mediating 
nonspecific interactions with host cells (Su et al. 1990). After reduction of disulphide bonds, 
MOMP can also function as a porin for nutrient uptake. The MOMP protein is encoded by the 
ompA gene and contains five conserved domains (CS1-CS5) with in between four variable 
domains (VSI – VSIV) which are localized at the outside of the bacterial membrane (Figure I-
5) (Stephens et al. 1987; Baehr et al. 1988a; Yuan et al. 1989). MOMP is an 
immunodominant protein and contains genus-, species- and serovar-specific epitopes 
(Caldwell et al. 1981). Moreover, mono- and polyclonal antibodies against MOMP are able to 
neutralize Chlamydiaceae infections both in vitro and in vivo (Caldwell and Perry 1982; 
Zhang et al. 1987). Therefore, MOMP is an interesting candidate for selection of both family- 
and species-specific antigens.  
Outer
membrane
Periplasm
Inner
membrane
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Figure I-5 Model of the positioning of the MOMP protein  in the outer membrane of the chlamydial cell 
wall. The conserved regions are represented as full lines and localized inside the outer membrane. The 
alternating lines represent the surface-exposed variable domains I to IV. Adapted from (Baehr et al. 1988b) (Kim 
and DeMars 2001). 
 
The second most abundant proteins in the EB outer membrane complex, OmcA and OmcB, 
are hardly present in RBs (Newhall 1987; Everett and Hatch 1995; Sanchez-Campillo et al. 
1999; Watts and Kennedy 1999). Both proteins are highly immunogenic and contain many 
conserved cysteine residues. OmcA, also known as ‘outer membrane protein 3’ (Omp3) or 
EnvA, is a lipoprotein with a molecular weight ranging from 9 kDa in C. trachomatis to 
12 kDa in C. psittaci. The OmcA protein is probably inserted into the outer membrane, 
considering the presence of the signal peptide (Everett and Hatch 1991).  
OmcB, also known as ‘outer membrane protein 2’ (Omp2) or EnvB, is a Chlamydiaceae-
specific protein that can be used as a marker for chlamydial infections (Sanchez-Campillo et 
al. 1999). This 60 kDa protein contains genus-specific epitopes and its sequence is highly 
conserved, suggesting a crucial function in the chlamydial life cycle (Watson et al. 1989; de la 
Maza et al. 1991). In contrast to C. trachomatis serovar E and C. psittaci 6BC, the OmcB 
protein of C. trachomatis LGV1 is surface exposed and functions as an adhesin (Watson et al. 
1994; Everett and Hatch 1995; Stephens and Lammel 2001; Fadel and Eley 2007, 2008).  
Polymorphic membrane proteins or Pmps are unique to Chlamydiales and were first 
discovered at the surface of C. abortus S26/3 (Longbottom et al. 1996). The number of Pmp 
genes varies from nine for C. trachomatis (Stephens et al. 1998) to 21 for C. pneumoniae 
(Kalman et al. 1999) and phylogentic analysis indicated the existence of six subfamilies (A, 
B/C, D, H, E/F and G/I) (Grimwood and Stephens 1999). Table I-2 gives an overview of the 
number of Pmp genes and the associated nomenclature for each chlamydial species, which is 
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based on the subfamily to which the protein belongs. All Pmp proteins are heterogeneous, 
both in amino acid sequence and in predicted size. The Pmps typically are rich in serine 
residues and contain multiple GGAI and FxxN motifs, repeated in the N-terminal half of each 
protein. These proteins resemble classical autotransporter proteins, with an N-terminal leader 
sequence for sec-dependent translocation across the membrane and a C-terminal β-barrel 
domain with a phenylalanine residue at the end, suggestive for their outer membrane 
localization. The central passenger domain (PD) is responsible for the protein's function and 
can remain surface-localized or be secreted (Henderson and Lam 2001; Dautin and Bernstein 
2007). Yet, it remains unclear if all Pmp genes are expressed and appear in the outer 
membrane (Grimwood et al. 2001; Tanzer et al. 2001). The existence of six Pmp subfamilies 
proposes at least six different functions, most likely in chlamydial virulence (Henderson and 
Lam 2001). Although specific roles have been described for only some Pmps, they are 
generally responsible for avoidance of the immune response while maximizing virulence 
(Tanzer et al. 2001; Tan et al. 2006).  
 
Table I-2 Overview of the number and associated nomenclature of the Pmp genes present in the different 
chlamydial species. (Tan et al. 2006) 
Species Number of Pmp genes Nomenclature 
Chlamydia trachomatis  9 A to I 
Chlamydia suis  9 A to I 
Chlamydia psittaci  21 An, Bn, Dn, En, Hn, Gn 
Chlamydia abortus  18 An, Bn, Dn, En, Hn, Gn 
Chlamydia pneumoniae  21 An, Bn, Dn, En, Hn, Gn 
Chlamydia caviae  17 An, Bn, Dn, En, Hn, Gn 
Chlamydia felis  12 An, Bn, Dn, En, Hn, Gn 
Chlamydia pecorum  15 An, Bn, Dn, En, Hn, Gn 
Chlamydia muridarum  9 A to I 
n represents a number 
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PorB or OmpB is a 37 kDa, cystein-rich protein, expressed in very low amounts and present 
in the outer membrane of EBs. The sequence is highly conserved among chlamydial strains 
and the protein probably functions as a substrate-specific porin, providing chlamydiae with 
dicarboxylic acids to compensate for the incomplete tricarboxylic acid cycle (Iliffe-Lee and 
McClarty 2000; Kubo and Stephens 2001). PorB-specific antibodies have neutralizing activity 
and where first discovered in human sera (Sanchez-Campillo et al. 1999). 
Omp85 is a highly conserved outer membrane protein and widely present in a wide range of 
Gram-negative bacteria and mitochondria. Omp85 is generally considered to be essential for 
cell viability and is involved in insertion of lipids and proteins into the bacterial outer 
membrane (Genevrois et al. 2003; Voulhoux et al. 2003). Omp85-specific antibodies 
neutralize chlamydial infections in vitro (Stephens and Lammel 2001).  
The chlamydial lipopolysaccharide (LPS) is present on both EBs and RBs and is a major 
antigenic component. This 10 kDa molecule has a lipid A part, containing two glucosamines 
(GlcN) bound to fatty acids, and contains a specific tri-saccharide of 3-deoxy-D-manno-oct-2-
ulopyranosonic acids (Kdo). Two of this Kdo residues are linked through a 2 → 8 linkage and 
this structure is unique for Chlamydiaceae (Brade et al. 1987).  
Heat shock proteins (Hsps) are present in the COMC of both EBs and RBs, and are 
considered to play an important role in chlamydial immunopathology (Zhong and Brunham 
1992). So far, the Hsp10, Hsp60 and Hsp70 proteins have been identified for Chlamydia 
(Kornak et al. 1991; Brunham and Peeling 1994). These proteins are structurally alike and 
highly conserved within chlamydial species. Moreover, Hsps are homologous to GroEL 
(Hsp60) and DnaK (Hsp70) of Escherichia (E.) coli and human mitochondria, with up to 50% 
protein sequence identity (Brunham and Peeling 1994).  
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7. Chlamydia suis infections in pigs 
7.1. Chlamydiaceae species  
To date, four chlamydial species are regularly observed in pigs: C. suis, C. abortus, 
C. pecorum and C. psittaci (Schautteet and Vanrompay 2011).  
Chlamydia psittaci primarily infects birds and these infections are often systemic and can be 
inapparent, severe, acute or chronic. Bacteria are mainly spread between birds by inhalation 
of contaminated aerosols, but transfer can also occur vertically, through the egg. 
Chlamydia psittaci has also been isolated from lungs and the genital tract of pigs (Busch et al. 
2000; Vanrompay et al. 2004) and is transmissible to humans. Clinical signs of human 
infections vary from mild flu-like symptoms to severe pneumonia (Beeckman and Vanrompay 
2009). The reference strain for C. psittaci is 6BC
T 
(=ATCC VR 125
T
).  
Chlamydia pecorum is a serologically and pathogenically diverse species and strains have 
been isolated from different mammal hosts including ruminants (cattle, sheep, goats) (Fukushi 
and Hirai 1992), koalas (Girjes et al. 1993) and swine (Kaltenboeck and Storz 1992; 
Anderson et al. 1996). Symptoms of infections range from reproductive disease, infertility 
and urinary tract disease to abortion, conjunctivitis, encephalomyelitis, enteritis, pneumonia 
and polyarthritis (Fukushi and Hirai 1992; Kaltenboeck and Storz 1992; Girjes et al. 1993; 
Anderson et al. 1996). The reference strain for C. pecorum is E58
T
 (=ATCC VR 628
T
). 
Chlamydia abortus is the most common cause of infectious abortion in sheep, also known as 
ovine enzootic abortion (OEA), in Europe, resulting in major economic losses in agriculture 
(Kerr et al. 2005). This species is endemic among ruminants, efficiently colonizing the 
placenta, but, can also infect swine, horses, rabbits, guinea pigs and mice (Everett et al. 
1999a; Longbottom and Coulter 2003). Moreover, miscarriages and stillbirths due to zoonotic 
C. abortus infections have been observed in woman who work with sheep (Johnson et al. 
1985; Wong et al. 1985; Herring et al. 1987; Janssen et al. 2006) and goats (Villemonteix et 
al. 1990; Pospischil et al. 2002a; Meijer et al. 2004b). The reference strain for C. abortus is 
B577
T
 (= ATCC VR 656
T
).  
Chlamydia suis is the most prevalent member of the Chlamydiacea occurring in pigs, which 
are the only confirmed natural hosts for this species (Schautteet and Vanrompay 2011). Its 
primary pathogenicity is proven by several experimental infections in gnotobiotic and 
conventionally raised pigs (Rogers and Andersen 1996; Rogers et al. 1996; Rogers and 
Andersen 1999; Reinhold et al. 2008b; Reinhold et al. 2010; De Clercq et al. 2014). 
Chlamydia suis seems to be widespread and the incidence of apparently asymptomatic 
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infections is high. However, C. suis infections are often also associated with conjunctivitis, 
enteritis, pneumonia and reproductive disorders (Rogers and Andersen 1996, 1999; Everett 
2000; Schautteet and Vanrompay 2011). Recent reports demonstrate the involvement of 
C. suis in several cases of conjunctivitis in humans in Nepal, suggesting a zoonotic potential 
for this chlamydial species (Dean et al. 2013b). 
7.2. Diagnosis of C. suis 
Chlamydial infections can be diagnosed via direct detection of the bacteria or bacterial 
components, or via screening for Chlamydiaceae-specific antibodies produced by the host. 
The available tests vary markedly in terms of sensitivity and specificity, however, each plays 
an important role in diagnosis. The ultimately applied test is dependent on a number of 
factors, including (a) the type of sample, (b) the viability of the organisms in the specimen, 
depending on the preservation and transport of the sample, (c) a possible presumptive 
diagnosis based on clinical symptoms and pathology, and (d) the clinical history. The 
following section overviews the main techniques used for diagnosis of C. suis.  
7.2.1. Culture 
Isolation of Chlamydiaceae in cell cultures is historically considered as the ‘gold standard’ for 
chlamydial diagnosis (Thejls et al. 1994). HeLa cells, derived from human cervical cancer, 
and McCoy cells, mouse fibroblasts, are predominantly used. In addition, Schiller et al. 
(2004) demonstrated that CaCo-2 cells, Human colonic adenocarcinoma, perform markedly 
better for isolation of C. suis, compared to African Green Monkey Kidney cells (Vero). In 
addition, Buffalo Green Monkey cells (BGM) are also regularly used for propagation of 
chlamydiae. However, culture of pig strains is problematic and its sensitivity is low. 
Therefore, a study was performed in our lab (unpublished results) to determine the growth 
characteristics of C. suis (strains S45, H7 and R24) on in six different cell lines [BGM, SK-6 
(swine kidney), IPEC-J2 (jejunal epithelium), Vero, McCoy, Caco-2]. The preferred cell line 
appeared to be strain dependent, and thus adaption of the cell line used for isolation to the 
nature of the sample might be recommended. Moreover, other than the requirement for 
advanced facilities and expertise, the need for rapid and cooled transport of samples for 
efficient recovery of chlamydial pathogens, reduces the suitability of culture for chlamydial 
screening. Still, culture remains essential to demonstrate the viability of a field strain, to 
generate and characterize new isolates and to study pathogenesis (Sachse et al. 2009). 
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7.2.2. Immunoassays 
Immunoassays for chlamydial antigen detection are not dependent on the viability of the 
bacteria and are easy to use. The vast majority of these tests is developed for detection of 
C. trachomatis infections in human clinical specimens and is based on the family-specific 
LPS antigen. Therefore, most of these assays should theoretically be suitable for detection of 
chlamydial infections in animals, however, the involved species cannot be identified. 
Immunoassays are available in different formats, including direct fluorescent antibody tests 
(DFA), plate-based ELISAs and solid-phase ELISAs [reviewed by Sachse et al. (2009)]. The 
main drawback is the varying sensitivity and specificity depending on the type of sample 
tested (Eggemann et al. 2000; Bagdonas et al. 2005). Therefore, many laboratories prefer 
serological methods or more specific and sensitive molecular approaches for detection of 
chlamydial infections in animals. The reference strain for C. suis is S45 (= ATCC VR 1474
T
). 
7.2.3. Serology 
Confirmation of infections through detection of anti-chlamydial antibodies in animal sera has 
been widely used to estimate the prevalence of infection. Presence of an antibody response 
may be the result of a present or prior infection. Therefore, serology is less adequate to 
distinguish infected from vaccinated animals. Moreover, there is a lag period between the 
moment of infection and the appearance of an antibody response, with a minimum of one to 
two weeks. In addition, infected animals are often asymptomatic with low or borderline levels 
of antibodies (Longbottom and Coulter 2003) and sera of piglets may contain maternal 
antibodies. Thus, serology and infection status are not fully correlated, which can complicate 
the interpretation of the results. In addition, the antibody response may be highly variable 
within a pig population and is dependent of the age of the animal. Therefore, sampling of 
multiple animals in a herd, preferably of different age, is necessary to get a realistic idea of 
the infection prevalence in a farm. Sampling at different time points enables the detection of 
titer changes, and an increase of the antibody titer is a more accurate indication of infections. 
Variance within serological tests themselves or due to laboratory circumstances can be 
considerable, requiring the analysis of all samples in the same batch. However, serological 
tests have some important advantages, such as the relatively straight forward sample 
collection and transport and the timing of sampling being less critical.  
Inclusions, elementary bodies (EBs) or chlamydial antigens are generally used to capture anti-
chlamydial antibodies. Subsequent detection of the bound antibodies is achieved by 
estimation of the consumption of complement, in a complement fixation test, or by use of 
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labeled secondary antibodies. Fluorescent markers are widely used for antibody labeling, in 
indirect immunofluorescence and micro immunofluoresence (MIF) tests. Besides, also other 
tags, like the horseradish peroxidase enzyme in indirect ELISA tests, are available [reviewed 
by Sachse et al. (2009)].  
Several serological assays were applied in order to determine the prevalence of 
Chlamydiaceae in pig sera. An LPS-based ELISA assay (Wittenbrink 1991) was used to 
estimate seroprevalence rates in German and Swiss pigs (Eggemann et al. 2000; Camenisch et 
al. 2004). Vanrompay et al. (2004) examined the Chlamydiaceae seroprevalence rate in 
Belgium with an ELISA based on the recombinant MOMP of an avian C. psittaci genotype D 
strain. The commercially marketed indirect haemagglutination assay (IHA kit; Lanzhou 
Veterinary Research Institute, Lanzhou, China) was used to study the prevalence of 
chlamydial infections in chinese pigs (Xu et al. 2010; Jiang et al. 2013; Zhang et al. 2014). 
Besides, also the LPS-based complement fixation test (CFT) is widely used to detect anti-
chlamydial antibodies in pig sera (Szeredi et al. 1996; Bagdonas et al. 2005; Rypula et al. 
2014a). However, these assays fail to identify the distinct chlamydial species occurring in 
swine. According to Di Francesco et al. (2006), the MIF test, using elementary bodies as 
antigens, is suitable to discern the involved chlamydial species. Nevertheless, recent studies 
raised serious doubts on the MIF test when applied for diagnosing human psittacosis 
(Verminnen et al. 2008). Moreover, results obtained by using chlamydial LPS or EBs should 
be interpreted with caution, since serological cross-reactions with antibodies against other 
pathogens may occur (Caldwell and Hitchcock 1984; Nurminen et al. 1984; Brade et al. 1987; 
Yuan et al. 1992). 
Although Hoezle et al. (2004) demonstrated the suitability of the entire MOMP protein of 
C. suis, C. abortus and C. pecorum to serologically identify the infecting chlamydial species 
in ELISA, no further efforts have been done to develop a species-specific MOMP-based 
assay. In fact, at present, no specific and sensitive assay is available for detection of 
antibodies produced in response to C. suis, the major species involved in chlamydial 
infections in swine.  
7.2.4. Immunohistochemistry 
Immunohistochemical staining of histological sections with monoclonal antibodies directed 
against chlamydial surface antigens, such as LPS or MOMP, are commonly used to detect 
chlamydial species for diagnostic purposes, as well as for epidemiological and pathogenesis 
studies (Juvonen et al. 1997; Tsakos et al. 2001; Hotzel et al. 2004; Navarro et al. 2004; Borel 
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et al. 2006a; Borel et al. 2006b). The used monoclonal antibodies are directly conjugated with 
the enzyme horseradish peroxidase or detected using a fluorescein-conjugated secondary 
antibody. Labeling can be enhanced using the streptavidin-biotin method (Szeredi et al. 1996; 
Buxton et al. 2002). Immunohistochemical staining procedures can be automated and are 
routinely applied in many laboratories. However, poor tissue penetration of the primary 
antibody may impair the sensitivity. In addition, the specificity of immunohistochemical 
assays is often poor due to a relatively high background caused by nonspecific binding of the 
antibodies with proteins, such as collagen, or the presence of endogenous peroxidases or 
biotin. Moreover, quantification of the amount of antigen present is challenging and the 
reproducibility is often low.  
7.2.5. Molecular diagnosis 
The introduction of molecular methods has considerably improved the sensitivity and 
specificity of the detection of chlamydiae. However, as a large number of PCR tests are 
currently in use, it is not always clear whether these tests have been properly validated 
(Sachse et al. 2009). For reasons of clarity, the following overview of available molecular 
diagnostic tests is therefore limited to the most relevant assays.  
Everett et al. (1999a) designed assays for amplification and sequencing of the 16S and 23S 
rRNA signature sequences. These assays are widely used and adapted to identify the involved 
chlamydial species (Becker et al. 2007; Englund et al. 2012; Di Francesco et al. 2013). 
Besides, also sequencing of the omp2 and ompA genes was applied for chlamydial species 
identification (Schiller et al. 1997a; Hoelzle et al. 2000; Kauffold et al. 2006). However, 
sequencing is time-consuming compared to other nucleic acid based tests, such as real-time 
PCR. Moreover, the sensitivity of the used assays is variable and sequencing is less attractive 
for large-scale studies. Therefore, other chlamydial species-specific nucleic acid amplification 
tests (NAATs) have been developed, which allow examination of the prevalence of 
chlamydiae in pigs. Sachse et al. (2005) designed a 23S rRNA gene based microarray 
hybridization assay for the identification of chlamydial species using the ArrayTube
TM
 (AT) 
platform (Clondiag Chip Technologies, Jena, Germany). This assay starts with a 
biotinylation-PCR, amplifying an 1-kbp segment of the rRNA operon. This initial PCR is not 
completely chlamydiae specific, since also E. coli DNA is amplified. The resulting amplicon 
is hybridized on a plastic tube-integrated microchip, containing 11 different probes. Detection 
is performed using the HRP-streptavidin conjugate, which enables signal amplification. 
Species identification is performed based on the obtained pattern of coloured spots. Borel et 
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al. (2008) calculated the sensitivity of the AT micro array using an entire panel of human and 
animal clinical samples, including 5 human pharyngeal swabs and 4 tissues of naturally 
infected diseased pigs. The sensitivity of the AT micro array was slightly lower than a 23S 
rRNA based real-time PCR (Ehricht et al. 2006). Pantchev et al. (2010) developed six 
separate real-time PCR assays for detection of all chlamydial species of veterinary interest 
(C. psittaci, C. abortus, C. pecorum, C. caviae, C. felis and C. suis). The ompA gene appeared 
suitable for discrimination of all species, except for C. suis. Instead, the 23S rRNA gene 
seemed to be a more convenient target. However, this PCR assay was developed for the 
examination of veterinary samples and cannot distinguish C. suis from the genetically closely 
related human pathogen C. trachomatis. Schautteet et al. (2013) used real-time PCR assays 
based on the ompA and 16S rRNA genes for detection of C. abortus (Livingstone et al. 2009), 
C. psittaci (Geens et al. 2005) and C. pecorum (Wan et al. 2011) in pig samples.  
 
7.3. Epidemiology 
7.3.1. Seroprevalence  
Although, there is a large variation in reported prevalence, Chlamydiaceae are believed to be 
widespread in the pig population worldwide (Schautteet and Vanrompay 2011). The 
serological epidemiology of C. suis is largely unknown, partly due to the inability of the 
available tests to determine the involved chlamydial species. Therefore, the majority of 
available data reports the prevalence of Chlamydiaceae on family level. Nevertheless, 
chlamydial infections are highly abundant in European commercial pigs. In Germany, 33% to 
72% of the sows and 10 to 47% of the boars produced Chlamydiaceae-specific antibodies 
(Eggemann et al. 2000). In Switzerland, seroprevalence rates were 62% for sows, 6.9% for 
piglets younger than four weeks and 48.1% for piglets older than four weeks (Camenisch et 
al. 2004). Moreover, 82.6% of the tested Swiss slaughter pig sera yielded positive anti-
chlamydial reactions (Szeredi et al. 1996). Chlamydiaceae-specific antibodies were detected 
in 63.5 to 80.3% of Italian slaughter pigs (Di Francesco et al. 2006). Chlamydial infections 
seem also endemic in Belgian pigs, since 96.5% of the examined farms were seropositive for 
Chlamydiaceae (Vanrompay et al. 2004). Bagdonas et al (2005) found seroprevalence rates 
of only 7.7% in Lithuanian pigs. In poland, only 5.65% of the examined pigs were positive 
for Chlamydiaceae-specific antibodies (Rypula et al. 2014b). Studies of the Chlamydiaceae 
seroprevalence rates of pigs in the different provinces of China revealed a relatively high 
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prevalence of 62.7% for the Hunan province, 58.59% in Jiangxi and 30.78% for the 
Guangdong province (Xu et al. 2010; Jiang et al. 2013; Zhang et al. 2014). Moreover, 
Chlamydiaceae-specific antibodies were demonstrated in 63.6% of Italian, free-living boars, 
suggesting wild boar populations may be Chlamydia reservoirs (Di Francesco et al. 2011).  
7.3.2. Molecular diagnosis 
Implementation of the recently developed species-specific NAATs revealed C. suis as the 
major species involved in chlamydial infections in swine. Becker et al. (2007) demonstrated a 
high prevalence of C. suis in the eyes of Swiss and German pigs without clinical symptoms 
(23-88%) or suffering from conjunctivitis (79-90%). Moreover, Di Francesco et al. (2013) 
detected C. suis in conjunctival swabs of wild boars in Italy. Chlamydia suis was involved in 
the vast majority of Belgian, German and Swiss pigs with chlamydial intestinal infections 
(Zahn et al. 1995; Szeredi et al. 1996; Schiller et al. 1997b). In Sweden, a high prevalence of 
C. suis was observed in growing pigs with or without diarrhea, and in slaughter pigs with or 
without conjunctivitis (Englund et al., 2012). Schautteet et al. (2013) demonstrated the 
presence of C. suis in the intestine and urogenital tract of Belgian, Cypryotic and Israelian 
sows suffering from reproductive disorders. Boar sperm may be the source of urogenital 
infections, since C. suis was found in boar semen of a German artificial insemination center, 
intended for export. The occurrence of C. suis in the urogenital tract was also confirmed in 
Polish pigs (Szymanska-Czerwinska et al. 2011).  
In Germany, mixed infections of C. suis and C. abortus were demonstrated in the lungs and 
intestines of pigs (Hoelzle et al. 2000). Similarly, C. psittaci and C. pecorum seem to be of 
lower significance although also C. pecorum DNA was found in boar sperm, fetuses and pig 
gut tissue (Thoma et al. 1997; Kauffold et al. 2006). Hotzel et al. (2004) demonstrated the 
presence of C. psittaci, C. abortus and C. suis in the lung tissue of a small population of wild 
boars in Thuringia (Germany), suggesting a possible wildlife reservoir of these bacteria.  
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7.4. Pathogenesis 
7.4.1. Experimental infections 
At present, 25 C. suis strains are described in literature (Table I-3), and all are isolated from 
pigs with clinical disease, with the exception of S45, 130 and 132. The pathogenicity of 
C. suis has been confirmed by experimental infections of gnotobiotic pigs with R19 and R27 
(intestinal lesions), R33 and DC6 (lung and nasal lesions) and H7 (conjunctivitis) (Rogers and 
Andersen 1996; Rogers et al. 1996; Rogers and Andersen 1999; Sachse et al. 2004; Reinhold 
et al. 2008b). Although the reference strain S45 was isolated from feces of an asymptomatic 
pig, experimental enteric infection of gnotobiotic piglets elicited significant enteric disease 
(Guscetti et al. 2009a). Interestingly, Pospischil et al. (2009a) observed aberrant C. suis 
developmental forms, indicative for a persistent infection in experimentally infected 
gnotobiotic pigs. Besides, administration of a C. psittaci isolate of pigeon origin (T49/90) 
resulted in a productive enteric infection with mild lesions, weak systemic dissemination, and 
fecal shedding, suggesting the pig as a potential host for avian Chlamydiaceae (Guscetti et al. 
2000). 
The role of C. suis and C. abortus in reproductive problems is experimentally less studied, 
partly due to the ethical objections associated with experimental infections of Chlamydiaceae-
negative sows, in different stages of gestation. Yet, De Clercq et al. (2014) demonstrated the 
pathogenicity of C. suis S45 for the pig female urogenital tract upon intravaginal infection. 
Chlamydia replication occurred throughout the urogenital tract, causing inflammation and 
pathology. Re-infection was characterized by less severe macroscopic lesions and less 
chlamydial elementary bodies and inclusions in the female reproductive tract. Inoculation of 
four sows with the BS ruminant C. psittaci serovar 1 strain at 42 days of gestation resulted in 
infection of fetal membranes, however, failed to induce abortion (Vazquezcisneros et al. 
1994).  
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Table I-3 Chlamydia suis strains isolated from pigs. Adapted from Schautteet and Vanrompay (2011) 
 Isolated from  
Strain Location Year Tissue Clinical Symptoms of the pigs 
S45 Austria 1969 Intestines (feces) Asymptomatic infection 
R19 Nebraska 1992 Intestines (feces) Pneumonia, enteritis, conjunctivitis 
R22 Nebraska 1992 Conjunctiva Conjunctivitis 
R24 Nebraska 1992 Respiratory tract (nasal mucosa) Upper respiratory tract disease 
R27 Nebraska 1993 Intestines (colon) Enteritis 
R33 Nebraska 1994 Respiratory tract (nasal mucosa) Pneumonia 
H5 Iowa 1994 Conjunctiva Conjunctivitis 
H7 Iowa 1994 Conjunctiva Conjunctivitis 
130 Nebraska 1996 Intestines (jejunum) Asymptomatic infection 
132 Nebraska 1996 Intestines (ileum) Asymptomatic infection 
DC6 Germany 2004 Conjunctiva Conjunctivitis 
MS1 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS2 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS3 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS4 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS5 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS6 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS7 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS8 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS9 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS10 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS11 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS12 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS13 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS14 Italy 2004-2007 Conjunctiva Conjunctivitis 
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7.4.2. Field studies 
Although experimental infections demonstrate its pathogenicity, the reported virulence of 
C. suis in commercial pigs is highly variable, possibly the consequence of the high degree of 
genetic diversity observed for C. suis compared to other chlamydial species (Everett et al. 
1999b; Bush and Everett 2001). In fact, intestinal C. suis infections have been frequently 
detected in clinically healthy and diarrheic pigs (Pospischil and Wood 1987; Zahn et al. 1995; 
Szeredi et al. 1996; Nietfeld et al. 1997; Hoelzle et al. 2000; Camenisch et al. 2004; Englund 
et al. 2012). Moreover, C. suis appears to be a common causative agent of conjuncitivitis 
(Rogers et al. 1993; Rogers and Andersen 1999). Becker et al. (2007) showed a significant 
correlation between the presence of C. suis and the occurrence of conjunctivitis in 
extensively-kept pigs. However, this correlation was not observed for intensive farming 
systems, where a high prevalence of C. suis was also demonstrated for clinically healthy pigs. 
Thus, intensively-kept pigs seem to be predisposed to ocular C. suis infections and associated 
conjunctivitis, as also observed by Schautteet et al. (2010). Besides, also the significance of 
C. suis and C. abortus in porcine respiratory disease has been confirmed in pigs suffering 
from bronchopneumonia (Hoelzle et al. 2000). In addition, chlamydiae have been linked to 
arthritis, pericarditis and polyserositis in piglets (Willigan and Beamer 1955; Kölbl 1969; 
Kölbl et al. 1970).  
Chlamydia suis is associated with numerous reproductive problems such as vaginal discharge, 
endometritis, return to oestrus, abortion, delivery of weak piglets, increased perinatal and 
neonatal mortality and mummification in sows (Woollen et al. 1990; Wittenbrink 1991; 
Schiller et al. 1997b; Camenisch et al. 2004; Kauffold et al. 2006; Schautteet et al. 2010; 
Schautteet et al. 2013). Moreover, C. suis, C. pecorum and C. abortus have been 
demonstrated in aborted foetuses (Schiller et al. 1997b; Thoma et al. 1997). Eggemann et al. 
(2000) found a significant correlation between the presence of chlamydial DNA and the 
incidence of abortion and litters with stillborn piglets and piglets with low viability. Hoelzle et 
al. (2000) demonstrated a significantly higher Chlamydia PCR positive rate for sows with 
reproductive disorders (mostly vaginal discharge) compared to healthy controls, although 
C. abortus was identified to be the causative agent in most cases and C. suis appeared to be 
less frequently present. In boars, C. suis infections have been linked to orchitis, epididymitis, 
urethritis and inferior semen quality (Sarma et al., 1983; Schautteet and Vanrompay, 2011). 
However, the exact role of C. suis still has to be clarified for most reproductive disorders.  
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Several studies suggest the appearance of clinical symptoms in pigs through synergistic 
interaction of chlamydiae with other pathogenic bacteria. Chlamydiae may induce intestinal 
lesions, albeit without clinical symptoms, altering susceptibility of the intestine for other 
enteropathogenic bacteria, as demonstrated for chlamydiae and Salmonella (Pospischil and 
Wood 1987). Schautteet et al. (2010) showed the impact of the co-occurrence of 
Chlamydiaceae (C. suis and C. abortus) and Porcine circovirus type 2 (PCV-2) during a 
concurrent outbreak of chlamydial disease in boars, sows and gilts and postweaning 
multisystemic wasting syndrome (PMWS) in weaned piglets on a large Estonian pig 
production plant. In fact, both pathogens can be present in healthy pig herds, but might trigger 
each other’s pathology. Similarly, co-infection of Acanthamoebae and C. suis was able to 
cause serious ocular manifestations in intensively-kept pigs (Becker et al. 2007).  
7.5. Antibiotic resistance  
Tetracyclines and its derivatives (chlortetracycline, oxytetracycline, doxycycline) are the 
drugs of choice for treatment of Chlamydia infections in most animal species because of their 
low cost, broad spectrum of activity, excellent tissue distribution and low toxicity (Michalova 
et al. 2004). Tetracyclines prevent interaction of aminoacyl tRNAs with ribosomes and thus 
block bacterial protein synthesis. Alternatively, Quinolones (enrofloxacin), macrolides 
(erythromycin) and erofloxacin can be administered, in case of an infection with a tetracycline 
resistant (Tc
R
) C. suis strain (Schautteet 2010).  
Until fifty years ago, live stock feed has been systematically supplemented with Tc to counter 
bacterial infections and to promote growth (Andersen and Rogers 1998; Di Francesco et al. 
2008). However, several antibiotic resistant strains of veterinary important pathogens arose. 
Given the associated risk of consumption of milk and meat originating from life stock fed 
with antibiotics, the in-feed use of Tc as growth promotor or preventive measure is no longer 
allowed in Europe since the late 1960’s, to avoid the creation of multi-drug resistant bacteria. 
Indeed, multi-resistant strains could have devastating and potentially irreversible effects on 
the viability of antibiotics as agents to effectively treat diseases in humans.  
The first C. suis strains, stably resistant to Tc, were isolated from diseased and normal pigs 
during the 1990’s in the USA, and some of these also exhibited a stable resistance to 
sulfadiazine (Andersen and Rogers 1998). Di Francesco et al. (2008) identified 14 additional 
Tc
R
 C. suis strains in Italy. Borel et al. (2012) demonstrated the rapid selection for tetracyline-
resistant C. suis after antibiotic treatment in a pig farm with an outbreak of conjunctivitis and 
diarrhea. The Tc
R
 phenotype is attributed to the presence of a foreign genomic island (ranging 
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from 6 to 13.5 kb) in the chlamydial chromosome. Four different genomic islands were 
identified, all carrying genes encoding a Tc efflux pump, tet(C), and a regulatory repressor, 
tetR (Dugan et al. 2004). The membrane associated Tc efflux pump prevents the Tc mediated 
inhibition of protein synthesis through export of Tc entering the bacterial cell. The regulatory 
repressor encoded by the tetR gene suppresses production of the Tc efflux pump and its 
function is neutralized through binding of the antibiotic (Chopra and Roberts 2001). Three of 
four tet(C) containing islands also carry a unique insertion sequence (IScs605). Dugan et al. 
(2007) demonstrated that a transposase within the IScs605 sequence is likely responsible for 
integration of the genomic islands into the C. suis chromosome. In all examined strains, the 
C. suis tet(C) is integrated in the inv-like gene, wherefore the exact function remains 
unknown. The tet(C) islands represent the first identification of antibiotic resistance acquired 
through horizontal gene transfer in any obligate intracellular bacteria, but, the exact nature of 
acquisition is still subject to scientific speculation. Yet, Tc resistance genes are widely 
distributed among pathogenic, opportunistic and normal flora bacteria isolated from man, 
animals and the environment (Roberts 1989; Roberts and Hillier 1990; Brown and Roberts 
1991; Roberts 1996). Indeed, Tc resistance genes are frequently isolated from pigs and soil 
and water samples from areas surrounding pig farms (Chee-Sanford et al. 2001; Stanton et al. 
2004; Koike et al. 2007; Stine et al. 2007). Moreover, the pig gut seems to be a source of Tc 
resistance genes, even in apparently antibiotic-free animals (Kazimierczak et al. 2009).  
The majority of Tc resistance genes is associated with mobile genetic elements which 
contribute to the distribution and maintenance of antibiotic resistance genes (Mendez et al. 
1980; Jones et al. 1992). It is likely that the extensive in-feed use of Tc established an 
environment in the intestines where the tet(C) gene could be acquired and maintained by 
C. suis (Dugan et al., 2004). However, the exact process through which the obligate 
intracellular bacterium C. suis required the tet(C) containing genomic island from other gram-
negative bacteria in the pig digestive tract remains completely uncharacterized (Suchland et 
al. 2009).  
So far, no stable antibiotic resistance have been reported in C. trachomatis isolates from 
human patients. A few cases of treatment failure displayed ‘heterotypic resistance’, a form of 
phenotypic resistance in which a small portion of an infecting microbial species is surviving 
after exposure to antibiotics. However, the isolates could not survive long-term passage or lost 
their resistance upon passage (Jones et al. 1990; Wang et al. 2005). Several alternative 
antibiotics are applied in clinical setting in case of treatment failure when using Tc. 
Genetically-based clinical resistance to these alternatives in Chlamydia has not been 
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documented so far. However, naturally occurring Tc and sulfadiazine doubly-resistant C. suis 
strains were already isolated from pigs in the USA (Andersen and Rogers 1998). In addition, 
Suchland et al. (2009) demonstrated the in vitro horizontal gene transfer of the Tc resistance 
gene from C. suis to C. trachomatis. Moreover, Lenart et al. (2001) showed that C. suis R19 
and C. trachomatis L2 could develop within a single inclusion after sequential in vitro 
infection, creating an environment where the two strains can interact. Hence, emergence of 
(multi-)resistant human chlamydial pathogens might be plausible and would represent a 
significant public health challenge.  
7.5.1. Persistence  
Failure of antibiotic therapy in the treatment of chlamydial infections is not always attributed 
to the acquisition of resistance genes. In fact, exposure of infected cells to beta-lactam 
antibiotics, IFN-gamma or deprivation of iron supplements or amino acids, induces a 
phenomenon called ‘persistence’. Persistent or ‘aberrant’ RBs proceed DNA replication and 
protein synthesis, but halt cell division. The resulting inclusions, containing small numbers of 
very large RBs, yield a prolonged infection caused by viable but non-culturable chlamydiae, 
that are refractory to antibiotic therapy. Removal of the inducing factor(s) results in septum 
formation, RB division and differentiation to EBs (Chopra et al. 1998; Hogan et al. 2004). 
Several studies demonstrate that long-term infections might lead to phenotypic resistance to 
antibiotics that are normally very effective in both C. trachomatis and C. pneumonia (Kutlin 
et al. 1999; Dreses-Werringloer et al. 2000; Kutlin et al. 2002). Consequently, it may be 
challenging to differentiate persistence induced by antibiotics from potential cases of 
antibiotic resistance in vivo, and this might lead to erroneous conclusions regarding the 
antibiotic resistance of clinical isolates. Moreover, a further understanding of long-term 
infections is important, because persistence may cause a cascade of potentially serious 
inflammatory-induced abnormalities, such as pelvic inflammatory disease, infertility, 
blindness, arthritis, asthma and atherosclerosis (Patton et al. 1994; Stamm 1999; Campbell 
and Kuo 2004; Burton and Mabey 2009; Gerard et al. 2009).  
7.5.2. Diagnostic considerations 
Antimicrobial susceptibility assays demand the isolation and culturing of the involved 
chlamydial strain in host cells. Previous isolation is also recommended for detection of the 
tet(C) gene using the PCR test developed by Dugan et al. (2004), since the assay is not 
Chlamydia-specific. Many different cell lines are used in different diagnostic laboratories and 
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there is no universal testing methodology. Small differences in technical approaches may 
influence the outcome significantly and complicate the interpretation of in vitro resistance and 
its association with clinical relevance. Although their specificity approaches 100%, culture-
based methods are time-consuming, require technical expertise and their sensitivity is often 
marginal. The sensitivity of NAATs is often 20-30% better than culture, however, the false 
positive rate can be considerable and the reproducibility is often low. All these technical 
issues present significant challenges in evaluating potential emergence of antibiotic resistance 
(reviewed by Sandoz and Rockey (2010)). 
7.5.3. Probiotics and vaccination 
Antibiotic treatment failure demands the use of alternative treatment methods, or prevention 
of infection by vaccination. Pollmann et al. (2005) demonstrated the reducing effect of a 
probiotic strain of Enterococcus faecium (NCIMB 10415) on the carryover of infections from 
Chlamydiaceae-infected sows to newborn piglets. The authors hypothesized that the probiotic 
strain may reduce the infection rate, likely through competition with chlamydiae for binding 
to the glucosaminoreceptor on the intestinal epithelial cells. Moreover, probiotic treatment 
might also influence the intracellular proliferation of chlamydiae in the host cell, or result in a 
more rapid elimination of Chlamydia-infected cells through modulation of the immune 
response. Further investigation could clarify the nature of the probiotic effect of 
Enterococcus faecium. The probiotic strain is licensed by the European Union as an animal 
feed supplement.  
So far, no vaccines are commercially available. However, a few preliminary studies towards 
vaccine development yielded promising results. Knitz et al. (2003) showed a marked primary 
and secondary IgG serum antibody response upon immunization of breeding sows with a 
formalin-inactivated C. abortus strain (OCHL03/99) originating from vaginal discharge of 
sows. Zhang et al. (2009) demonstrated a protective immune response in mice against 
C. abortus infections following co-vaccination of a DNA vaccine and recombinant MOMP. 
Moreover, the results obtained by De Clercq et al. (2014) indicate that an initial vaginal 
C. suis infection creates partial protection against re-infection. The latter is promising for the 
development of an effective vaccine. Research towards vaccination is worthwhile since 
vaccination would be an effective strategy to prevent C. suis infections and the associated 
clinical problems.  
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7.6. Zoonosis 
 
Chlamydiae are among the most prevalent microorganisms in animals. The most prominent 
zoonotic examples are C. abortus and C. psittaci (Beeckman and Vanrompay 2009). 
Chlamydia psittaci is transmitted to humans through aerosols from infected birds and their 
excretions and causes human psittacosis, also called ornithosis or parrot disease. The clinical 
course of this condition is usually severe, resembling the symptoms of influenza and 
eventually pneumonia. The disease can be fatal without antibiotics treatment. The avian 
strains of C. psittaci are belonging to risk group 3 (Directive 2000/54/EC), due to the danger 
of human infections (Perry 1973; Salisch et al. 1996). Chlamydia abortus infected animals are 
a potential danger for pregnant women, since several reports notify spontaneous abortions and 
potentially fatal systemic infections in pregnant women after exposure to infected sheep or 
goats (Buxton 1986; Kampinga et al. 2000a; Pospischil et al. 2002a; Walder et al. 2003; 
Walder et al. 2005b).  
Little is known about the transmission of chlamydial pathogens from pigs to humans. Yet, the 
most prevalent chlamydial species in pigs, C. suis, is highly related to C. trachomatis (Everett 
et al. 1999b). This human pathogen is the most common bacterial sexually transmitted disease 
in the world (Bebear and de Barbeyrac 2009). Besides, ocular C. trachomatis infections can 
give rise to trachoma, the leading cause of preventable blindness in developing countries 
(WHO 2008). Chlamydia suis is frequently isolated from the eyes of pigs suffering from 
conjuncitivitis (Rogers et al. 1993) and was also involved in eye infections causing 
conjunctivitis in human patients in Nepal (Dean et al., 2013). Hence, C. suis might be a 
zoonotic pathogen and transfer to humans could have clinical consequences for public health. 
Further epidemiological and clinical research towards human C. suis infections is of 
significant importance.  
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Abstract 
Pigs are the natural host for Chlamydia suis, a pathogen which is phylogenetically highly 
related to the human pathogen C. trachomatis. Chlamydia suis infections are generally treated 
with Tc. In 1998, tetracyline resistant C. suis strains emerged on U.S. pig farms and they are 
currently present in the Belgian, Cypriote, German, Israeli, Italian and Swiss pig industry. 
Infections with Tc
R
 C. suis strains are mainly associated with severe reproductive failure 
leading to marked economical loss. We developed a sensitive and specific TaqMan probe-
based C. suis real-time PCR for examining clinical samples of both pigs and humans. The 
analytical sensitivity of the real-time PCR is 10 rDNA copies/reaction without cross-
amplifying DNA of other Chlamydia species. The PCR was successfully validated using 
conjunctival, pharyngeal and stool samples of slaughterhouse employees, as well as porcine 
samples from two  farms with evidence of reproductive failure and one farm without clinical 
disease. Chlamydia suis was only detected in diseased pigs and in the eyes of humans. 
Positive humans had no clinical complaints. PCR results were confirmed by culture in McCoy 
cells. In addition, Chlamydia suis isolates were also examined by the tet(C) PCR, designed for 
demonstrating the Tc resistance gene tet(C). The tet(C) gene was only present in porcine C. 
suis isolates.  
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1. Introduction 
Chlamydiaceae are obligate intracellular Gram-negative bacteria that cause a broad range of 
diseases in both humans and animals. Pigs can become infected by Chlamydia (C.) pecorum, 
C. abortus, C. psittaci and C. suis (Everett et al. 1999b). Seroprevalence rates of 
Chlamydiaceae in German, Swiss, Italian and Belgian pigs are high (40-96%) (Eggemann et 
al. 2000; Camenisch et al. 2004; Vanrompay et al. 2004; Di Francesco et al. 2006). As far as 
known, the pig is the only host for C. suis, which is phylogenetically closely related to the 
human pathogenic agent C. trachomatis (Everett et al. 1999b). Chlamydia suis infections can 
be asymptomatic or associated with arthritis, pericarditis, polyserositis, pneumonia, 
conjunctivitis, enteritis, diarrhea and reproductive failure (Willigan and Beamer 1955; Sarma 
et al. 1983; Woollen et al. 1990; Zahn et al. 1995; Andersen and Rogers 1998; Eggemann et 
al. 2000). Experimental infections in specific pathogen free and gnotobiotic pigs using C. suis 
field strains have resulted in conjunctivitis, respiratory lesions and gastrointestinal lesions 
(Reinhold et al. 2008b; Guscetti et al. 2009b; Pospischil et al. 2009b). To date, transmission 
of C. suis to humans has not been reported (Schautteet and Vanrompay 2011). However, 
C. suis and C.  trachomatis are closely related (Everett et al. 1999b) and, therefore, the 
zoonotic potential of C. suis is likely.  
Chlamydia suis can be difficult to grow in cell culture or embryonated eggs (Schautteet and 
Vanrompay 2011). A molecular diagnostic test, able to specifically detect C. suis in both 
animal and human samples, is crucial to gain insight into the prevalence, the economic impact 
and the zoonotic ‘threat’ of C. suis infections. In 2006, Sachse et al. (2005), developed a 23S 
rDNA gene-based array tube (AT) micro array for detection and differentiation of Chlamydia 
spp. The assay detects a single copy of the cloned target DNA (Ehricht et al. 2006). Borel et 
al. (2008) calculated the sensitivity of the AT micro array over an entire panel of human and 
animal clinical samples, including five human pharyngeal swabs and four tissues of naturally 
infected diseased pigs. The sensitivity of the AT micro array was slightly lower than for real-
time PCR. When excluding long-time stored swab samples from the calculation, the 
sensitivity was equivalent to that of real-time PCR. However, in our hands, C. suis species 
identification by use of the AT microarray was often only possible on isolates of vaginal and 
rectal swabs and not directly on these clinical samples (Schautteet et al. 2013). More recently, 
Pantchev et al. (2010) developed a 23S rDNA gene-based real-time PCR for C. suis. 
However, the PCR was strictly developed for the examination of veterinary samples as it 
cannot distinguish C. suis from the genetically closely related human pathogen C. trachomatis 
36   Chapter II 
 
(Pantchev et al. 2010). Therefore, the present study aimed to develop a sensitive and specific 
C. suis real-time PCR for the purpose of examining clinical samples of both pigs and humans.  
 
2. Materials and methods 
2.1. Bacterial cultures 
For determination of sensitivity, specificity and detection limit of the C. suis-specific real-
time PCR, the following 14 chlamydial strains were used: C. suis strains S45, R19, H7, R24, 
R27 and R33, C. pneumoniae (TW-183), C. felis (FP Baker), C. caviae (GIPC), C. abortus 
(S26/3), C. psittaci (92/1293), C. pecorum (1710S), C. muridarum (MoPn) and 
C. trachomatis (L2/434/BU). Bacteria were grown in cycloheximide treated McCoy cells 
(mouse fibroblast cells, obtained from Els De Coster, Labo Medische Analyse, CRI, 
Zwijnaarde, Belgium; original source: ATCC CRL-1696) using a standard methodology, as 
described previously (Vanrompay et al. 1992). Chlamydiae were released from infected 
monolayers (two passages) by freezing and thawing, followed by ultrasonication (Bransonic 
12, BIOMEDevice, San Pablo, CA, USA). Cell culture harvest was centrifuged for 10 min 
(1000 × g, 4°C) and chlamydiae were subsequently concentrated by ultracentrifugation for 45 
minutes (50,000 × g, 4°C). Bacteria were resuspended in 2 mL sucrose phosphate glutamate 
buffer (SPG, 218 mM sucrose, 38 mM KH2PO4, 7 mM K2HPO4, 5 mM L-glutamic acid) and 
stored at –80°C until use.  
2.2. DNA extraction 
Genomic DNA of bacterial cultures was prepared using the DNeasy Blood and Tissue Kit 
(Qiagen, Antwerp, Belgium). DNA extraction of clinical samples was performed using the G-
spin Total DNA Extraction Mini Kit (Goffin Molecular Biotechnologies, Beek, The 
Netherlands). Both extraction methods were performed according to the instructions of the 
manufacturers.  
2.3. Primers and probes 
Published 23S ribosomal RNA sequences of all known chlamydial species (Table II-1) 
(Everett et al. 1999b) were aligned using Clustal X software (default settings) (Thompson et 
al. 1997). Forward and reverse primers (Life technologies, Paisley, United Kingdom) and 
probes (Eurogentec, Seraing, Liège, Belgium) were designed using primer3 software 
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(Skaletsky 2000) (Table II-2). Primer and probe specificity was checked by BLAST 
(Thompson et al. 1997). The optimal annealing temperature and specificity of the primers and 
probes within the genome was evaluated in 20 µl PCR reactions containing 3µl of 2µM of 
forward and reverse primers, 0.5 µl Super Taq 5U/µl (Sphaero Q, Gorinchem, The 
Netherlands), 2µl Super Taq Reaction Buffer, 2 µl of each of 1.25 mM dNTP and 50 ng of 
genomic DNA of C. suis strain S45. The cycling conditions were as follows: 72°C for 5 
minutes; 35 cycles of 95°C for 60s, 60°C for 60s and 72°C for 60s and a final step of 72°C for 
5 min. CS23S-probe A and B were 5’ labeled with the reporter dye 6-carboxyfluorescein 
(FAM) and hexachloro-fluoresceine (HEX) respectively, and 3’ labeled with the quencher dye 
carboxytetramethylrhodamine (TAMRA).  
 
Table II-1  NCBI Nucleotide Accession numbers of the 23S rRNA gene sequences used for the alignment 
to design the primers and C. suis specific probes. 
Species Strain NCBI Nucleotide  Accession Number 
C. suis R22 U68420 
C.  trachomatis L2/434/BU U68443 
C. abortus EBA U76710 
C. psittaci NJ1 U68419 
 6BC U68447 
C. pecorum IPA U68434 
C. felis FP Baker U68457 
C. muridarum MoPn U68436 
 SFPD U68437 
C. caviae GPIC U68451 
C. pneumoniae TW-183 U76711 
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Table II-2 Primers and probes of the C. suis specific real-time PCR. 
Name Sequence (5’- 3’) Positiona Specificity 
CS23S-F GCAGAGGAAAAGAAATCGAAGA 215-236 
C. suis and 
C. trachomatis 
CS23S-R CGGGACTATCACCCTGTATC 359-378 
C. suis and 
C. trachomatis 
CS23S-ProbeA FAM-CGAGCTGAAGAAGCGAGGGGTTGTAG-TAMRA 280-305 C. suis 
CS23S-ProbeB HEX-CGAGCCGAAGAAGCGAGGGGTTGTAG-TAMRA 280-305 C. suis 
a
 Binding position from base 1 of the 23S rRNA gene of the chlamydial reference strain S45. 
2.4. Inhibition control plasmid 
The 23S rDNA amplicon of C. suis (S45) was amplified using 20 µl PCR reactions containing 
3µl of 2µM of forward and reverse primers, 0.5 µl Super Taq 5U/µl (Sphaero Q, Gorinchem, 
The Netherlands), 2µl Super Taq Reaction Buffer, 2 µl of each of 1.25 mM dNTP and 50 ng 
of genomic DNA. PCR products were purified using the Wizard SV Gel and PCR Clean-Up 
System (Promega, Madison, WI, USA) and cloned into pGemT (Promega, Madison, WI, 
USA) according to the manufacturer’s protocol. To verify the nucleotide sequence of the 
inserted fragment, sequence analyses were performed by the VIB Genetic Service Facility 
(University of Antwerp, Antwerp, Belgium) using vector associated T7 and SP6 priming sites. 
The resulting C. suis-species-specific internal inhibition control plasmid was designated 
pGemT::CSIC.  
2.5. Species-specific real-time PCR 
Real-time PCR was performed with the Rotor-Gene Q Instrument (Qiagen Benelux, Venlo, 
The Netherlands) using 25 µl reaction mixture containing 2 µl of DNA template, 4 µl of 
primer mixture (300 nM forward and reverse primer), 2.5 µl of CS23S-probe A and B (200 
nM), 12.5 µl of absolute qPCR mix (Thermoscientific, Acros Organics, Geel, Belgium) and 
1.5 µl DNAse and RNAse free water. The cycling conditions were as follows: 95°C for 15 
minutes, 50 cycles of 95°C for 15 seconds, 60°C for 60 seconds. All default program settings 
were used. Standard graphs of the Cycle threshold (Ct) values, obtained by testing tenfold 
serial dilutions (10
8
 to 10
1
) of the purified species-specific inhibition control plasmid, were 
used for quantification. DNA was always tested in the presence of control plasmid (50 
copies/µl) to check for PCR inhibitors. 
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2.6. Detection limit and specificity  
The lower detection limit of the assay was evaluated using decimal serial dilutions (10
6
 to 10
1
 
copies/µl) of the inhibition control plasmid and of purified genomic DNA of the C. suis 
reference strain S45 from suspensions equivalent to 10
6
 to 10
1
 copies/µl. Three independent 
dilution series were analyzed and reactions were performed in triplicate. The specificity was 
evaluated using: i) genomic DNA from C. peumoniae (TWAR), C. felis (FP Baker), C. caviae 
(GPIC), C. abortus(S26/3), C. psittaci (92/1293), C. pecorum (1710S), C. muridarum (MoPn) 
and C. trachomatis (L2/434/BU) as well as ii) DNA from 23 and 38 bacterial species 
commonly found in swine and humans, respectively, and iii) genomic DNA from swine and 
human tissues (Table II-3 and 4).  
 
Table II-3 Organisms of non-chlamydial origin found in swine and used for specificity testing. 
Organisms* 
Acinetobacter calcoaceticus Clostridium novyi Mycoplasma hyopneumoniae 
Bacteroides coprosuis Enterobacter cloacal Mycoplasma hyosynoviae 
Bacteroides pyogenes Enterobacter aerogenes Pasteurella multocida 
Bordetella bronchiseptica Enterococcus faecalis Pseudomonas aeruginosa 
Bordetella pertussis Enterococcus durans Proteus mirabilis 
Bordetella parapertussis Escherichia coli  Proteus vulgaris 
Brachyspira hyodesenteria Klebsiella pneumoniae Salmonella Typhimurium 
Brachyspira pilosicoli Lactobacillus fermentum Staphylococcus aureus 
Brucella suis Lactobacillus acidophilus Staphylococcus hyicus 
Clostridium perfringens Lactobacillus delbrueckii Streptococcus suis 
* Identification of micro-organisms was performed by culture on selective media, biochemical identification and 
molecular characterization methods like PCR and DNA sequencing. 
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Table II-4 Organisms of non-chlamydial origin found in humans and used for specificity testing. 
Organisms* 
Acinetobacter baumannii Eubacterium cylindroides Propionibacterium acnes 
Bacteroides fragilis Eubacterium lentum Pseudomonas aeruginosa 
Bifidobacterium adolescentis Eubacterium hadrum Proteus mirabilis 
Bifidobacterium longum Eubacterium ventriosum Proteus vulgaris 
Bordetella bronchiseptica Faecalibacterium prausnitzii Ruminococcus luti 
Citrobacter braakii Klebsiella oxytoca Salmonella enterica 
Citrobacter freundii Klebsiella pneumoniae Serratia marcescens 
Clostridium botulinum Lactobacillus acidophilus Shigella dysenteriae 
Clostridium difficile Lactobacillus plantarum Shigella flexneri 
Clostridium perfringens Lactobacillus gasseri Shigella sonnei 
Clostridium tetani Stenotrophomonas maltophilia Staphylococcus aureus 
Corynebacterium urealiticum Moraxella catarrhalis Staphylococcus epidermidis 
Enterobacter aerogenes Morganella morganii Moraxella catarrhalis 
Enterococcus faecalis Mycoplasma pneumoniae Streptococcus agalactiae 
Enterococcus faecium Peptostreptococcus magnus Streptococcus mitis 
Escherichia coli Peptostreptococcus asaccharolyticus Streptococcus nilleri 
Eubacterium nodatum Peptostreptococcus anaerobius Streptococcus pyogenes 
Eubacterium biforme Streptococcus pneumoniae Veillonella parvula 
* Identification of micro-organisms was performed by culture on selective media, biochemical identification and 
molecular characterization methods like PCR and DNA sequencing.  
 
2.7. Case studies 
2.7.1. Pig farms  
To validate the performance of the C. suis real-time PCR, vaginal swabs originating of 10 to 
15 sows from three Dutch pig (A, B, C) farms were tested. Two of the three farms were 
dealing with cases of reproductive failure (decrease of the conception rate from 90 to <65%, 
1-3% abortions, sows that delivered only two to five piglets of a non-uniform weight, white to 
yellow non-smelling vulval liquid, irregular return to estrus). Clinical disease did not improve 
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following medication with doxycycline [400 g (ton feed) 
-1
] plus a combination of 
trimethoprim [120 g (ton feed) 
-1
] and sulfamethoxazole [600 g (ton feed) 
-1
] for 10–14 days 
during gestation and half of these drug concentrations during lactation. Antibody detection or 
PCR for Leptospira species, Mycoplasma species, Brucella suis, porcine reproductive and 
respiratory syndrome virus, Aujeszky’s disease, swine influenza, porcine circovirus 2 and 
porcine parvovirus, were negative. Tests were performed at the Dutch Animal Health Service 
(Deventer, The Netherlands) and by the Flemish Animal Health Service (Drongen, Belgium). 
The third farm reported no clinical problems and was included as a negative control.  
Animals were sampled for C. suis culture and PCR. For culture, rayon-tipped aluminum-
shafted swabs (Copan; Fiers, Kuurne, Belgium) were immersed in chlamydia transport 
medium (Vanrompay et al. 1992) immediately after vaginal sampling and stored at -80°C for 
culture. For PCR, vaginal swabs immersed in DNA/RNA stabilization buffer (Roche) were 
stored at -80°C. All DNA extractions were performed using the G-spin Total DNA Extraction 
Mini Kit (Goffin Molecular Biotechnologies, Beek, The Netherlands) according to the 
manufacturer‘s protocol.  
Purified DNA of vaginal swabs was analyzed by the newly developed C. suis-specific real-
time PCR. Presence of viable chlamydiae was determined by inoculation on McCoy cells (in 
duplicate) followed by  direct immunofluorescence (anti-LPS/FITC) staining on the first 
culture drum at six days post inoculation (Imagen, Oxoid, Drongen, Belgium). If positive, the 
second culture drum was used for C. suis identification by use of the newly developed real-
time PCR. Positively identified C. suis isolates were also examined by the tet(C) PCR, 
designed for demonstrating the Tc resistance gene tet(C) (Dugan et al. 2004), For this 
purpose, we used genomic DNA of the Tc
R
 C. suis strain R19 (Rogers and Andersen 1996) as 
positive control. 
All animal samples were received from veterinary practitioners and were delivered for 
diagnostic purpose. Therefore, approval of the veterinary ethical committee was not required.  
 
2.7.2. Slaughterhouse employees 
Validation of the C. suis PCR for human diagnosis was performed by sampling abattoir 
workers. During a yearly medical checkup, employees of a Belgian pig slaughterhouse were 
asked (informed consent) to voluntarily provide a pharyngeal and conjunctival swab, as well 
as a swab of fresh stool. Rayon-tipped aluminum-shafted swabs were immersed in chlamydia 
transport medium (Vanrompay et al. 1992) and stored at -80°C until culture. Swabs for PCR 
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were immersed in DNA/RNA stabilization buffer and stored at -80°C. Purified DNA was 
analyzed by the newly developed C. suis-specific real-time PCR. Presence of viable 
chlamydiae, identification of viable C. suis and the presence of the tet(C) gene in C. suis 
strains was examined as mentioned for the pig farms. 
The case study was approved by the medical ethical committee (approval EC UZG 2011/459). 
Participants provided their written informed consent and the consent procedure was approved 
by the medical ethical committee of Ghent University.  
 
3. Results 
3.1. Primers and probes  
It was impossible to design C. suis-specific primers in the 23S rDNA target region, such that 
the forward and reverse primers would also not anneal to C.°trachomatis DNA. However, we 
were able to design C. suis-specific probes for real-time PCR. The differentially labeled 
probes CS23S-A and CS23S-B were C. suis-specific and they were both required for 
coverage of the selected target region of all known C. suis strains. Forward (CS23S-F) and 
reverse (CS23S-R) primers generated a PCR product of 159 bp.  
 
3.2. Internal inhibition control 
Standard curves made using 10
6
 to 10
1 
copies of the pGemT::CSIC control plasmid 
(Figure II1) showed slopes around -3.103, which correlates to an efficiency of 109%, with 
correlation coefficients > 98%.  
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Figure II-1 Real-time PCR quantitation of chlamydial S45 genomic DNA (A) and pGemT::CSIC control 
plasmid (B). The standard curve data points are the average of 3 replications, standard deviations are shown as 
error bars. The equations and R
2
 linearity values resulting from the linear regression analysis are shown on the 
graphs. 
 
3.3. Species-specific real-time PCR 
The species-specific real-time PCR detected all known C. suis strains. Amplification of 
genomic DNA extracts of all C. suis strains resulted in the expected PCR products with 
amplification curves exceeding the 0.02 threshold before cycle 25. The species-specific PCR 
was able to detect 10 rDNA copies (or two copies/µl) of both genomic and control plasmid 
DNA, as demonstrated through analysis of the serial decimal dilutions of plasmid and 
genomic DNA. Standard curves resulting from the sensitivity analysis are shown in Figure II-
1. The slopes were around -3.5, which correlates to an efficiency of 91%, with correlation 
coefficients > 99%. The species-specificity test revealed a Ct-value of 19 for DNA of 10
6
 
TCID50 C. suis. Real-time PCR on genomic DNA of C. pneumoniae, C. felis, C. caviae, 
C. pecorum, C. abortus, C. muridarum and C. trachomatis generated  no signal. The real-time 
PCR gave no results for genomic DNA of other pathogens commonly found in the eyes, 
respiratory or urogenital tract of swine and humans, neither with DNA from swine or human 
tissues. 
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3.4. Case studies 
3.4.1. Pig farms 
Chlamydia suis was not detected on the clinically healthy farm C. The pathogen was present 
on farms A and B, both dealing with reproductive failure. Chlamydia suis DNA was found in 
all (100%) vaginal swabs of farms A and B. Viable C. suis organisms were present in 7 of 10 
(70%) and 11 of 15 (73.3%) vaginal swabs of farms A and B, respectively. Chlamydial 
isolates of farm A and B were examined for the presence of the tet(C) gene. The tet(C) gene 
was discovered in two of seven (28.5%) and 6 of 11 (54.5%) C. suis isolates of farms A and 
B, respectively. Clinical symptoms disappeared after treatment with enrofloxacin 
(fluoroquinolone, Baytril 5 %; Bayer Healthcare), as previously described (Schautteet et al. 
2012). Enrofloxacin was added to the sperm diluter [2 ml (l diluter) 
-1
] and it was also used to 
rinse the sow’s reproductive tract (Baytril 5%, 5 ml+95 ml distilled water) immediately before 
artificial insemination. Infected sows were re-examined two weeks after treatment and were 
negative in both PCR and culture. 
3.4.2. Slaughterhouse employees 
Only 12 of 84 (14.3%) employees voluntarily participated. They provided 12 conjunctival, 12 
pharyngeal and 12 stool swabs. Pharyngeal swabs and stool were all C. suis negative. Two of 
12 (16.6%) conjunctival swabs were positive by the newly developed C. suis real-time PCR, 
revealing a Ct-value of 26 and 28, respectively. Real-time PCR results on all swabs could be 
confirmed by culture. Culture harvest of both positively identified C. suis isolates was 
negative by the tet(C) PCR. Positive employees worked daily for three years in the pig gut 
washing area and for eight years in the animal reception area, respectively. Clinical signs 
were absent.  
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4. Discussion 
Chlamydial infections are treated with Tc. In 1998, Tc
R
 C. suis strains emerged in the U.S. pig 
industry (Iowa and Nebraska), and are currently also known to be prevalent in the Belgian, 
Cypriote, German, Israeli, Italian and Swiss pig industry (Andersen and Rogers 1998; Lenart 
et al. 2001; Camenisch et al. 2004; Di Francesco et al. 2006; Borel et al. 2012). The present 
study adds a country to the list, since it is the first report on Tc
R
 C. suis strains in the Dutch 
pig industry. The C. suis Tc
R
 phenotype is manifested through the Tc resistance gene tet(C). 
Tet(C) is integrated into the chlamydial chromosome (Dugan et al. 2004), but it is a 
transposable genetic element, which is also present in other bacteria such as E. coli.  
The international economic consequences of C. suis infections are not yet fully established, 
but the financial loss due to severe reproductive failure and the need for antibiotic treatment 
currently worries pig producers all over the world. Moreover, pig farmers are aware of the 
existence of Tc
R
 C. suis strains and the risk of importing Tc
R
 C. suis contaminated sperm for 
artificial insemination (Schautteet et al. 2013) (and P. Delava, personal communication 2014). 
Furthermore, emergence of Tc
R
 chlamydial strains might pose a potential threat for public 
health if this species turns out to be a zoonotic pathogen. Suchland et al. demonstrated in vitro 
horizontal transfer of the Tc resistance gene among chlamydial species (Suchland et al. 2009). 
Therefore, contact between Tc
R 
and
 
Tc
S 
Chlamydia spp. could lead to transfer of the tet(C) 
gene and the subsequent phenotype, which could then be propagated and selected for in 
patients that are treated with Tc. However, the lack of evidence of antibiotic resistance 
leading to treatment failure in humans seems to indicate that horizontal transfer of the tet(C) 
gene is rather rare. Sandoz and Rockey (Sandoz and Rockey 2010) state that unsufficiency of 
the current diagnostic methods, could be the cause of this lack of evidence.  
In this respect, studying the presence of C. suis in humans, dealing with pigs on a regular 
basis, is meaningful. Thus, there is an urgent need for a highly sensitive and specific 
molecular diagnostic test to study the epidemiology of C. suis in pigs and to study a possible 
transfer of C. suis to humans.  
Real-time PCR technology offers the possibility to automatically combine amplification, 
specific hybridization and detection in one single test. It allows specific and sensitive gene 
quantification with a minimal contamination risk, as  the AmpErase UNG system can be 
incorporated in order to prevent post-PCR carry-over of amplified DNA. The technique has 
been used successfully to detect C. pneumoniae (Kuoppa et al. 2002; Tondella et al. 2002; 
Welti et al. 2003; Hardick et al. 2004), C. trachomatis (Solomon et al. 2003), C. felis (Helps 
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et al. 2001; Sykes et al. 2001; Helps et al. 2003), C. pecorum (DeGraves et al. 2003), 
C. psittaci (Geens et al. 2005), and C. abortus (Pantchev et al. 2010).  
Although, the high genomic sequence similarity between C. suis and C. trachomatis made it 
difficult to design a sensitive C. suis-specific PCR, the analytical sensitivity of the assay was 
10 rDNA copies/reaction (or two copies/µl). Besides, the C. suis real-time PCR contains two 
differentially labeled probes. Albeit differentially labeling is not required for the detection of 
all C. suis strains, their use creates the ability to differentiate the two ‘groups’ of C. suis 
strains which are distinguished by one single SNP in the target region.  
The C. suis-specific real-time PCR is suitable for diagnosis in swine as successfully 
demonstrated in the present case report. Importantly, the C. suis-specific real-time PCR is also 
suitable for human samples, as it distinguishes C. suis from i) the human pathogens 
C. trachomatis and C. pneumoniae and ii) the currently known zoonotic species: C. felis, 
C. abortus and C. psittaci.  
The detection of C. suis DNA as well as viable C. suis in the eyes of two slaughterhouse 
employees illustrates the value of this assay in future investigations on the zoonotic potential 
of C. suis. Becker et al. (2007) showed intensively raised pigs to be pre-disposed to 
chlamydial associated conjunctivitis. Transmission from infected pig eyes to humans is 
perhaps not unusual in highly irritant environments like a slaughterhouse and intensive pig 
farms. C. suis positive persons had no clinical complaints and they showed no disease 
symptoms. We detected only low amounts of C. suis in the eyes, and perhaps C. suis only 
ended up in the eyes by touching face/eyes with contaminated hands. Possibly, it was just an 
eye “contaminant” and not a real infection. Perhaps serology would have clarified this issue. 
However, employees refused to give blood during our experiment. Thus, future studies in 
humans should include the detection of C. suis-specific antibodies in serum or at least in 
conjunctival swabs. None of the participating employees was infected with C. trachomatis 
and both C. suis isolates were Tc
S
. Therefore, further research is needed, sampling larger 
human risk populations, to estimate the prevalence of C. trachomatis and Tc
R
 C. suis strains 
in people working with pigs. Besides, the potential of C. suis to cause pathology in the human 
eye needs to be examined in more detail, especially since C. suis is phylogenetically highly 
related to C. trachomatis, the etiology of human trachoma and as a recent study by Deborah 
Dean also found C. suis in the human eye (Dean et al. 2013a).  
In conclusion, we designed and validated a C. suis-specific real-time PCR for use in swine 
and humans. The assay can be used for detection and monitoring of C. suis strains in pigs and 
for examining their zoonotic potential more extensively. Additionally, the real-time PCR 
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could be useful for systematic screening of boar sperm in insemination centers. The ability to 
detect C. suis in semen enables implementation of the appropriate measures to prevent the 
spread through international trade of boars and sperm.  
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Abstract 
A significant number of studies on pig farms and wild boars worldwide, demonstrate the 
endemic presence of Chlamydia suis in pigs. However, the zoonotic potential of this 
pathogen, phylogenetically closely related to Chlamydia trachomatis, is still uninvestigated. 
Therefore, this study aims to examine the zoonotic transmission in a Belgian pig abattoir. 
Presence of Chlamydia suis in pigs, contact surfaces, air and employees was assessed using a 
Chlamydia suis specific real-time PCR and culture. Furthermore, Chlamydia suis isolates 
were tested for the presence of the tet(C) gene. Chlamydia suis bacteria could be 
demonstrated in samples from pigs, the air and contact surfaces. Moreover, eye swabs of two 
employees were positive for Chlamydia suis by both PCR and culture. The tet(C) gene was 
absent in both human Chlamydia suis isolates and no clinical signs were reported. These 
findings suggest the need for further epidemiological and clinical research to elucidate the 
significance of human ocular Chlamydia suis infections.  
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1. Introduction 
The negative influence of Chlamydiaceae infections on the economic yield of the pig industry 
is underestimated (Schautteet and Vanrompay 2011). Four chlamydial species are regularly 
observed in the pig population: Chlamydia (C.) pecorum, C. abortus, C. psittaci and C. suis 
(Schautteet and Vanrompay 2011). Chlamydia suis is the most prevalent and its primary 
pathogenicity is proven by several experimental infections in gnotobiotic pigs (Rogers and 
Andersen 1996; Rogers et al. 1996; Rogers and Andersen 1999; Reinhold et al. 2008b; 
Guscetti et al. 2009a; Pospischil et al. 2009a; Reinhold et al. 2010). In the field, this pathogen 
is mainly associated with respiratory disease, diarrhea, conjunctivitis, reproductive failure and 
subclinical infections (Pospischil et al. 2009a; Schautteet and Vanrompay 2011). Chlamydiae 
are generally highly sensitive to the relatively inexpensive Tc antibiotics. However, the first 
tetracyline resistant (Tc
R
) C. suis strains appeared in the U.S. in 1998 (Andersen and Rogers 
1998). Ever since, infections with C. suis strains have been reported on  Italian (Di Francesco 
et al. 2008; Di Francesco et al. 2011), Estonian (Schautteet et al. 2010), Belgian, Cypriot, 
German, Israeli (Schautteet et al. 2013), Swiss (Borel et al. 2012) and Dutch (De Puysseleyr 
et al. 2014b) pig farms. The majority of these infections were due to Tc
R
 C. suis strains. 
Moreover all of these farms suffered from severe reproductive failure leading to marked 
economic loss. 
Exposure to Tc
R
 C. suis strains poses an additional risk for pig handlers. In fact, Suchland et 
al. (Suchland et al. 2009) demonstrated horizontal transfer of the Tc resistance gene tet(C) 
among chlamydial species.  
The use of Tc antibiotics as treatment for chlamydial infections in pigs, leads to selection for 
resistant strains (Borel et al. 2012). Consequently, the emergence of Tc
R
 strains requires the 
use of other, more expensive antibiotics and, may become economically devastating to pig 
production. Besides the economical consequences, Tc
R 
C. suis strains are also a potential 
threat to public health. Contact between Tc
R 
C. suis and
 
Tc
S
 C. trachomatis bacteria might 
lead to creation of a Tc
R
 C. trachomatis strain in persons infected with both strains. 
Nevertheless, the co-infection of a person with C. suis and C. trachomatis is only possible if 
C. suis is a zoonotic bacteria. Albeit the zoonotic potential of C. suis is still unexamined, the 
zoonotic transfer of C. suis is a plausible hypothesis since C. suis is phylogenetically highly 
related to C. trachomatis, a natural pathogen of humans (Everett et al. 1999b). Therefore, the 
present study examines the prevalence of C. suis in slaughter pigs (100 kg) being 
slaughtered in a Belgian abattoir, and simultaneously investigates zoonotic transmission. For 
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this purpose, slaughterhouse employees, air and possible direct contact surfaces were 
sampled. Pigs, air and contact surfaces were diagnosed for Tc
R 
C. suis, while humans were 
examined for Tc
R 
C. suis and C. trachomatis. As far as known, the present study is the first 
evaluation of the zoonotic potential of C. suis in a pig slaughterhouse. 
 
2. Materials and Methods 
2.1. Sampling of pigs and humans 
Rayon-tipped aluminium-shafted swabs (Copan; Fiers, Kuurne, Belgium) were used to 
sample pigs and humans. For monitoring C. suis in pigs, rectal swabs (n=100; 10 pigs of 10 
Belgian farrowing to slaughter farms) were taken upon arrival in the slaughterhouse. No 
information on clinical signs or medication during the fattening period was available. 
Sampling was performed on one day. A swab for PCR was placed in DNA/RNA stabilization 
buffer (Roche) and a swab for culture was immersed in chlamydia transport medium (2-SP). 
At the same day, employees voluntarily provided (informed consent) an ocular and 
pharyngeal swab, and they were asked to bring a fresh stool swab and a first void morning 
urine sample the next day. All samples were kept at 4°C and they were stored at 80°C upon 
arrival in the laboratory. Volunteers filled out a medical questionnaire, in the presence of a 
medical doctor, to assess information on professional (work environment of the employee) 
and nonprofessional activities, general health status, smoking habits, use of medication, 
allergies and clinical signs.  
This study was approved by the medical ethical committee of Ghent University (approval EC 
UZG 2011/459). Participants provided their written informed consent and the consent 
procedure was approved by the medical ethical committee. 
 
2.2. Sampling of air and contact surfaces 
Bioaerosol monitoring for C. suis was performed using the MAS-100 Eco sampler (Merck, 
Darmstadt, Germany) as previously described (Dickx et al. 2010) at different locations in the 
abattoir: the pig reception area (lairage and stunning), slaughtering and bleeding area, pre-
washing bath location, dehairing area, cutting/deboning area, carcass splitting area, organ 
evisceration area, individual weighing area, chilling/hanging room, pig intestine washing 
room, employee dining room, and the administrative office. In addition, also contact surfaces 
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were sampled (water taps, door handles, tables, knives, start and stop button of machines) at 
all these locations by use of rayon-tipped aluminium-shafted swabs (Copan; Fiers, Kuurne, 
Belgium). Swabs were examined by PCR and culture. In addition, we also sampled water taps 
and door handles at the sanitary facilities at the individual weighing area, the pig intestine 
washing room and the cloakrooms.  
 
2.3. DNA extraction 
DNA extraction on urine samples was performed using the High Pure PCR Template 
Preparation (HPPTP) Kit (Roche Molecular Biochemicals, Mannheim, Germany), according 
to the manufacturers’ protocol (version 16.0). DNA extraction of swabs and Chlamydia cell 
culture harvest was performed as described by Wilson et al. (Wilson et al. 1996).  
 
2.4. Chlamydia suis PCR 
Pig swabs were examined by real-time PCRI, a 23S rRNA-based real-time PCR detecting 
C. suis in pigs (Pantchev et al. 2010). However, this PCR analysis cannot be used for 
examining transfer of C. suis to humans, as it also detects C. trachomatis. Therefore, all pig 
and human samples were also examined by real-time PCRII, a recently developed C. suis-
specific 23S rRNA-based real-time PCR (De Puysseleyr et al. 2014b). This allowed the 
comparison between real-time PCRI and II, for examining C. suis. Similarly, all air and 
contact surface samples were analysed with PCRI and II. Samples with a Ct-value below 35 
cycles, were retested. Only repeatedly positive samples were judged as positive. Genomic 
DNA of the C. suis reference strain S45 was used as positive control DNA (10
5
 particles per 
reaction), and DNAse –RNAse free water as negative control.  
 
2.5. Chlamydia trachomatis PCR 
All ocular and pharyngeal swabs and urine samples of the employees were tested for presence 
of C. trachomatis DNA using the CE-IVD certified PRESTO Kit (Goffin Molecular 
Diagnostics, Houten, The Netherlands) according to manufacturer’s instructions (Schuurs et 
al. 2013).  
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2.6. Culture 
All samples were examined for viable chlamydial bacteria in cycloheximide-treated Vero 
cells using standard techniques (Vanrompay et al. 1992). Positive cells were enumerated in 
five randomly selected microscopic fields (600 x, Nikon Eclipse TE2000-E, Japan) and 
results were scored from 0 to 6. Score 0 indicated that no chlamydiae were present; Score 1 
was given when a mean of 1 to 5 non-replicating elementary bodies (EB’s) plus maximum 
one inclusion (elementary and replicating reticulate bodies) with multiplying EB’s was 
observed; scores 2 to 5 were given when observing a mean of 2 to 5, 6 to 10, 11 to 15, 16 to > 
90% inclusion positive cells (Lagae et al. 2014). 
 
2.7. Molecular characterization of Chlamydia isolates 
Chlamydial isolates were molecularly characterized by real-time PCRII (De Puysseleyr et al. 
2014b) and DNA sequence analysis of the 16S (298 bp) and 23S (627 bp) signature sequences 
of Chamydia (Everett et al. 1999b). Sequence analyses were performed by the VIB Genetic 
Service Facility (University of Antwerp, Antwerp, Belgium).  
 
2.8. Tet(C) PCR 
Chlamydia suis isolates of pigs and humans were examined for presence of the Tc resistance 
gene by the tet(C) PCR, as described by Dugan et al. (Dugan et al. 2004).  
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3. Results 
3.1. Chlamydia suis in pigs 
Rectal swabs of 100 pigs were examined by real-time PCRI and II. Real-time PCRI revealed 
45 (45%) positives. The Ct-values varied between 26.6 and 32. PCRII discovered 7 additional 
positives, resulting in a final number of 52 positives on 100 (52%) pigs, with the number of 
positives per farm ranging from 2 (20%) to 10 (100%). This finding is consistent with the 
reported higher sensitivity of PCRII (De Puysseleyr et al. 2014b) compared to PCRI 
(Pantchev et al. 2010). The Ct-value of real-time PCRII varied between 16.8 and 30.1. PCRII 
positive pigs were found on all farms. The percentage of PCRII positive pigs per farm ranged 
from 10 to 100%. Fifteen of 52 (28.8%) PCR positive pigs excreted C. suis, as demonstrated 
by PCRII and DNA sequencing of 16S and 23S signature sequences of obtained Chlamydia 
isolates. Those 15 culture positives originated from 8 of 10 examined farms. Three of 15 
(20%) C. suis isolates contained the tet(C) gene (Figure III-1). Chlamydia suis tet(C) positives 
were found on 3 of 10 farms. 
 
 
Figure III-1 Results of the Tc resistance PCR performed on swine and human Chlamydia suis isolates. 
Three Chlamydia suis strains isolated from pigs were tetC positive. The other 12 obtained swine isolates, 
whereof three are represented, and both human isolates, were tetC negative. 
 
3.2. Chlamydia suis and Chlamydia trachomatis in humans 
Only 12 of 84 (14.3%) employees participated. The age of the participants varied between 25 
and 60 years with an average of 43 years. The set of 48 human samples comprised: 12 
conjunctival, 12 pharyngeal, 12 stool and 12 urine samples, which were all examined for 
C. suis and C. trachomatis. Samples were negative for C. trachomatis. Pharyngeal, stool and 
urine samples were negative for C. suis by both real-time PCRI and II. However, 2 of 12 
(16.6%) conjunctival swabs were positive in real-time PCRII, showing Ct-values of 26 and 
28, respectively. Those two swabs were negative by real-time PCRI. Positive real-time PCRII 
results were confirmed by culture (both score 1), as we isolated C. suis from both conjunctival 
swabs (Figure III2). None of the human C. suis isolates contained the tet(C) gene 
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(Figure III1). Both C. suis positive employees worked daily in the abattoir. One of them 
worked in the pig intestine washing room during the last three years and the other person was 
responsible for the bleeding of the pigs during the last eight years. They had no clinical signs 
or disease complaints while being examined by the occupational physician, nor did they 
mention having symptoms related to eye infections, ever since working in the slaughterhouse. 
 
  
Figure III-2 Micrographic image of one of the obtained human C. suis isolates. The larger green spot, 
adjacent to the red stained cell nucleus, represents a chlamydial inclusion. The small green dots, indicated with a 
white arrow, are chlamydial EBs. This image corresponds to a culture score of 1. (Magnification 400x) 
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3.3. Chlamydia suis on contact surfaces 
Contact surfaces were all negative by real-time PCRI. Real-time PCRII could discover C. suis 
DNA, albeit small amounts (Ct-values ranging from 32.5 to 34.1) on contact surfaces of nine 
of the 14 sampled work locations in the slaughterhouse. For six of these locations, positive 
real-time PCRII results were confirmed by culture (culture score 1) (Table III1).  
 
Table III-1 Results of the molecular analyses on contact surface samples at different locations in the 
abattoir.  
Location PCRII Viable C. suis 
Pig reception area - - 
Slaughtering and bleeding area  + + 
Pre-washing bath location - - 
Dehairing area + + 
Cutting/deboning area - - 
Carcass splitting area + - 
Organ evisceration area - - 
Individual weighing area + + 
Chilling/hanging room - - 
Pig intestine washing room + - 
Employee dining room + + 
Sanitary facilities at the individual wheighing area + - 
Sanitary facilities at the pig intestine washing room + + 
Sanitary facilities at the cloakrooms + + 
Total (positives/examined) 9/14 6/14 
Swabs in DNA/RNA stabilization buffer were used to detect the presence of C. suis DNA by use of PCRI and II. 
The results of the PCRII analysis are mentioned in column ‘PCRII’. Swabs in 2-SP medium were inoculated on 
Vero-cells for evaluation of the presence of viable chlamydiae. Culture positive chlamydial isolates were 
analyzed using PCRII for subsequent molecular detection of C. suis. Results are shown in column ‘viable 
C. suis’. All culture positive samples showed isolation score 1. 
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3.4. Chlamydia suis bioaerosol monitoring 
Air samples were all negative by real-time PCRI. Real-time PCRII could discover small 
amounts of C. suis DNA (Ct-values ranging from 32.5-34.12) in the air of seven of ten 
sampled locations. Positive real-time PCRII results were confirmed by culture for five of 
these locations (Table III2).  
Table III-2 Results of the molecular analyses on air samples at different locations in the abattoir.  
Location PCRII Viable C. suis Isolation score 
Pig reception area + - 4 
Slaughtering/bleeding area + - - 
Pre-washing bath location + + 2 
Dehairing area + + 2 
Organ evisceration area + + 1 
Individual wheighing area - - - 
Chilling/hanging room + + 2 
Pig intestine washing room + + 4 
Dining room - - - 
Administration office - - - 
Total (positives/examined) 7/10 5/10  
All samples were used for direct detection of C. suis DNA, by use of PCRI and II (results in column ‘PCRII’), 
for inoculation on Vero cells (results in column ‘Isolation score’) and subsequent identification of C. suis 
(column ‘viable C. suis’). 
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4. Discussion 
The present study examines the occurrence of Tc
R
 C. suis strains in slaughter pigs being 
slaughtered in a Belgian abattoir and, at the same time, is focusing on zoonotic transmission 
of C. suis. Chlamydia suis infections are emerging worldwide in the pig industry (Schautteet 
and Vanrompay 2011). Increased awareness of veterinarians and improved diagnostics might 
explain, albeit partially, the increasing number of reports on C. suis outbreaks in pigs (Sachse 
et al. 2005; Pantchev et al. 2010). However, we are unaware if contact with C. suis infected 
pigs presents a public health risk, in particular for pig farmers and abattoir employees. After 
all, C. suis is phylogenetically highly related to the human pathogen C. trachomatis (Everett 
et al. 1999b). Moreover, both pathogens cause infections of the eye and urogenital tract in 
their natural hosts (Schautteet and Vanrompay 2011). Recently, Dean et al. examined 101 
conjunctival samples of trachoma (preventable blindness) patients who resided in a trachoma-
endemic region of Nepal (Dean et al. 2013b). They found two C. suis infections and five 
mixed C. trachomatis plus C. suis infections, all leading to trachomatous inflammation. 
Hence, zoonotic transmission is likely.  
Besides, the number of reports on Tc
R
 C. suis infections in pigs is augmenting (Andersen and 
Rogers 1998; Lenart et al. 2001; Camenisch et al. 2004; Di Francesco et al. 2008; Borel et al. 
2012; Schautteet et al. 2013). In 2010, Schautteet et al. demonstrated tet(C) positive C. suis 
strains in 10 examined Belgian farms and in 8 on 49 (16.3%) sick pigs ending up in the 
autopsy room of DGZ-Animal Health Care Flanders (Schautteet et al. 2010). Hence, the 
previously reported epidemiology of C. suis in Belgian pigs is confirmed by the present study 
since we found tet(C) positive C. suis strains in 8 of 10 examined Belgian farms. Therefore, a 
pig slaughterhouse is a confirmed risk environment to study the zoonotic transfer of C. suis. 
Employees provided urine and ocular, pharyngeal and fresh stool swab specimens for both 
PCR and culture. Two of 12 examined employees tested positive for C. suis by PCR and 
culture. However, only 12 of 84 employees participated, which was low compared to former 
similar studies on C. psittaci zoonotic transmission in poultry abattoirs (Dickx et al. 2010). 
Analysis of the answers on all questionnaires indicated that there were no clinical complaints, 
and the yearly routine medical examination revealed no clinical signs of infection, although 
viable C.  suis were found in the eyes of two employees. Both individuals worked for several 
years in the abattoir, in the pig intestine washing room and in the slaughtering and bleeding 
area, respectively. Thus, exposure to blood and intestinal contents might present a source of 
C. suis for transmission to humans, but it is not strictly leading to a symptomatic course of 
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infection. Employees may be regularly exposed to C. suis and therefore could have natural 
immunity against disease. Serological analyses could have clarified this issue, however, 
employees did not give their consent for blood sampling. Contact surfaces at both locations 
were equally positive by both PCR and culture. Thus, Chlamydia suis could have ended up in 
the eyes through direct contact of hands with ‘contaminated’ contact surfaces. Besides, 
bioaerosol monitoring demonstrated high amounts (score 4) of viable C. suis in the air of the 
the intestine washing room. However, the air of the slaughtering and bleeding area was 
negative in isolation, suggesting the air is not the main C. suis transmission route. 
Nevertheless, sampling was only performed at one time point and may not completely reflect 
the actual exposure. Repeated sampling might clarify this issue. Further studies on larger risk 
populations should be conducted to get more insight into transmission routes and clinical 
consequences of C. suis in humans. 
 
Conclusion 
The present study shows the presence of viable C. suis bacteria in the eyes of two employees 
and in air samples and contact surfaces along the slaughter line. None of the human C. suis 
isolates contained the tet(C) gene and both humans were negative for C. trachomatis. 
However, the adaptive ability of C. suis to acquire the tet(C) gene, especially when exposed to 
selective pressure, and the possibility of C. suis transfer to humans could have far-reaching 
consequences for public health. Preventive measures might reduce the risk of C. suis transfer 
to slaughterhouse employees. Besides, further epidemiological and clinical research towards 
human ocular C. suis infections is of great importance.  
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Abstract 
Chlamydia suis is widespread among commercial pigs and clinical consequences of infections 
are well documented. The appearance of Tc
R
 strains and recent reports on zoonotic transfer of 
Chlamydia suis, have raised concerns on the risk associated with the emergence of Tc
R
 
Chlamydia trachomatis strains, leaving antibiotic treatments ineffective, possibly affecting 
millions of people worldwide. In this context, detection of Chlamydia suis antibodies in swine 
and human sera to confirm infections in swine and humans is indispensable. However, a 
Chamydia suis-specific serodiagnosis assay is currently unavailable. This present study aims 
to identify an antigenic and Chlamydia suis specific peptides for serodiagnostic use. Three 
promising candidate proteins were selected based on a literature overview of the knowledge 
obtained from other species. The respective protein sequences were aligned to identify 
Chlamydia suis-specific peptides. Sequence alignments and software-based antigenicity 
analysis were combined with the in vitro screening for Chlamydia suis-specific antigens using 
a panel of control sera of pigs. The use of an additional set of molecularly-characterized field 
sera demonstrated the suitability of two peptide antigens for use in serodiagnosis of C. suis in 
swine. Although further optimization of the assay is required and the specificity of the 
antigens for C. suis remains to be confirmed using C. trachomatis antisera, one of the peptides 
is as well promising for development of an assay for serodiagnosis in humans.  
 
The results represented in this chapter will be used to file a patent application. 
Therefore, the identity of the selected candidate proteins or peptide sequences will not 
be disclosed.  
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1. Introduction 
Chlamydiaceae species are well known pathogens, and cause a wide variety of symptoms in 
both animals and humans (Longbottom and Coulter 2003). Beside the well documented 
zoonotic potential of Chlamydia (C). abortus and C. psittaci, only recently, a few studies 
report the isolation of C. suis strains from human eyes (Dean et al. 2013b; De Puysseleyr et 
al. 2014a). The source of a zoonotic C. suis infection is the pig, the only animal host for this 
bacteria. Although C. suis is considered to be the most prevalent chlamydial species, pigs can 
also become infected by C. pecorum, C. abortus and C. psittaci (Schautteet and Vanrompay 
2011). Porcine chlamydial infections are not always associated with symptoms, but if so, they 
lead to important economical losses due to arthritis, pericarditis, polyserositis, pneumonia, 
conjunctivitis, enteritis, diarrhea and reproductive failure (Willigan and Beamer 1955; Sarma 
et al. 1983; Woollen et al. 1990; Zahn et al. 1995; Andersen and Rogers 1998; Eggemann et 
al. 2000). Diagnosed infections are commonly treated with Tc antibiotics, however, more and 
more Tc
R
 C. suis strains are emerging (Andersen and Rogers 1998; Di Francesco et al. 2008; 
Schautteet et al. 2010; Di Francesco et al. 2011; Borel et al. 2012; Schautteet et al. 2013). In 
vitro transfer of the antibiotic resistance genes between chlamydial species is demonstrated by 
Suchland et al. (Suchland et al. 2009). These findings raise another point of concern 
associated with the possible zoonotic character of C. suis. Co-infection of a human individual 
with a Tc
R
 C. suis and the phylogenetically closely related human pathogen C. trachomatis, 
creates the ideal setting for transfer of the resistance gene and emergence of a Tc
R
 
C. trachomatis strain. To avoid creation of multi-resistant strains, comprehensive knowledge 
about the epidemiology and infection biology of C. suis is required. Recent efforts were done 
to develop C. suis specific molecular tests (De Puysseleyr et al. 2014b; Lis et al. 2014) and to 
apply these analyses to investigate the presence of C. suis in a human risk population (De 
Puysseleyr et al. 2014a). However, the presence of viable C. suis bacteria in animal or human 
samples may still be a result of contamination and is no foolproof evidence for an existent 
infection. Additional serological tests to demonstrate an anti-C. suis antibody response may 
show the presence of an immunological response and thus confirm the zoonotic transfer of 
C.suis. Unfortunately, at present, no assay for C. suis specific serodiagnosis is available.  
Numerous serological assays targetting chlamydial antigens or anti-chlamydial antibodies are 
published (Sachse et al. 2009). Assays based on detection of antibodies directed against the 
full length proteins or peptides from the surface exposed lipopolysaccharide (LPS) 
(Wittenbrink et al. 1991), major outer membrane protein (MOMP) (Vanrompay et al. 2004), 
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polymorphic outer membrane proteins (Pmps) (Longbottom et al. 2001) or whole elementary 
body (EB) preparations (Di Francesco et al. 2006), were developed with varying degrees of 
success in terms of sensitivity and specificity. Nevertheless, no studies to identify the major 
reactive antigens of C. suis have been published until today. Therefore, a literature overview 
of the knowledge obtained from other species was used during the present study to select 
protein candidates for identification of antigenic and C. suis specific peptides to develop a 
serological test. For reasons of confidentiality in view of valorization, the identity of the 
selected candidates is not disclosed in this thesis. Instead, the respective proteins are 
designated ProteinA, B and C.  
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2. Materials and Methods 
2.1.  Bacterial strains 
The following strains were used for production of experimental sera in 4-weeks-old piglets: 
C. suis strains S45, R19 and H7; C. abortus (S26/3); C. psittaci (98AV2129); C. pecorum 
(1710S). Bacteria were grown in cycloheximide treated McCoy cells according the standard 
methodology described previously (Vanrompay et al. 1992). Chlamydiae were released from 
infected monolayers by freezing and thawing prior to ultrasonication (Bransonic 12, 
BIOMEDevice, San Pablo, CA, USA). Cell culture harvest was centrifuged for 10 min 
(1000xg, 4°C) and bacteria were subsequently concentrated by ultracentrifugation for 45 
minutes (50.000xg, 4°C). Chlamydiae were resuspended in 2 ml sucrose phosphate glutamate 
buffer (SPG, 218 mM sucrose, 38 mM KH2PO4, 7 mM K2HPO4, 5 mM L-glutamic acid) and 
stored at –80°C until use. 
2.2.  Pig sera 
Sera were derived from non-infected, naturally infected and experimentally 
infected/immunized pigs. For experimental infection of four-weeks-old SPF pigs, 10
6
 bacteria 
were administered orally, intravaginally and via aerosolization. Two pigs were inoculated 
with the C. suis reference strain S45. In addition, one pig was infected for each of the C. suis 
strains H7 and R19, the C. abortus S26/3 strain, and the C. psittaci 98AV2129 strain. Pigs 
were euthanized four weeks post infection.  
For immunization of four-weeks-old SPF piglets, 10
6
 bacteria (of the C. abortus strain S26/3 
or C. pecorum 1710S) were mixed with equal volumes of complete Freund’s adjuvant (CFA; 
Sigma, Diegem, Belgium) and injected subcutaneously. Two weeks later, immunization was 
repeated to boost antibody production using incomplete Freund’s adjuvant (Sigma, Diegem, 
Belgium). Pigs were euthanized three weeks after booster immunization and blood was 
collected. Immunization and infection experiments were approved by the medical ethical 
committee of Ghent University (approval EC2012/078).  
Naturally infected pigs were sampled in a Belgian pig slaughterhouse. Blood and rectal swabs 
were collected from 83 animals, originating from 8 different farms. No information 
concerning the health status or antibiotic treatment of the sampled pigs was available. Swabs 
were stored in DNA/RNA stabilization buffer (Roche, Brussels, Belgium) at -80°C for PCR 
analysis. DNA extraction was performed using the G-spin Total DNA Extraction Mini Kit 
(Goffin Molecular Biotechnologies, Beek, The Netherlands) according to the instructions of 
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the manufacturer. The resulting DNA extract was analyzed using a C. suis specific real-time 
PCR (De Puysseleyr et al. 2014b), to confirm the presence of C. suis in the sampled pigs.  
Additionally, a set of 10 sera originating from 4-weeks-old SPF-piglets were used as negative 
control sera.  
All blood samples were incubated overnight at room temperature. Sera were collected, heat 
inactivated for 30 min at 56°C and kaolin treated to reduce background reading (Novak et al. 
1993). Four volumes of a kaolin suspension (25% (w/v) in PBS; pH 7.4) were added to one 
volume of serum and incubated at room temperature for 30 min. The samples were 
centrifuged (5500xg for 10 min) and the supernatant was stored at -20 °C.  
All sera were tested for the presence of anti-MOMP antibodies in a direct ELISA using 
C. trachomatis recombinant MOMP (CT rMOMP ELISA) as antigen (Schautteet et al. 2011). 
The test allows the detection of family-specific MOMP antibodies since the family specific 
epitope is located in the conserved region of MOMP (Stephens et al. 1998). The positive cut-
off value was calculated as the mean of the OD-values of negative control pigs sera plus twice 
the standard deviation.  
 
2.3. Selection of the peptides 
2.3.1. ProteinA 
The ProteinA amino acid sequences of C. suis MD56 were compared to the sequences of the 
reference strains A/Har-13 and L2/434/BU (C. trachomatis). The clustal omega program was 
used to construct multiple sequence alignments, using default parameters (Thompson et al. 
1997). Nine regions were selected as templates for production of 152 synthetic peptides, 
which were produced by Pepscan Systems (Lelystad, The Netherlands). Peptides were eight 
amino acid residues in length, with an overlap of six residues. All peptides contained an N-
terminal acetyl group and were C-terminal attached to polyethylene pins via incorporation of 
an extra cysteine at an amount of 100 µg per pin. The peptide coated pins were assembled on 
a polyethylene carrier in a ‘96-well format’. This enables the use of the pins for an ELISA 
assay in a 96-well microplate (referred to as ‘pinELISA’).  
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2.3.2. ProteinB and ProteinC 
Identification of the C. suis specific regions using amino acid sequence alignments was 
combined with an epitope prediction of the identified sequences, for selection of a specific 
and antigenic peptide. Alignments were constructed with the clustal omega program using 
default parameters (Thompson et al. 1997). The strains used to create the ProteinB and 
ProteinC alignments are listed in Table IV- 1.  
The B-cell epitope prediction of the identified C. suis specific regions was performed using 
tools provided by the Immune Epitope Database Analysis Resource (IEDB analysis resource; 
http://tools.immuneepitope.org/main/index.html). This website offers a collection of six tools 
for the prediction of linear epitopes from protein sequences (Chou and Fasman Beta-Turn 
(Chou and Fasman 1978), Emini surface Accessibility (Emini et al. 1985), Karplus and 
Schulz Flexibility (Karplus and Schulz 1985), Kolaskar and Tongaonkar Antigenicity 
(Kolaskar and Tongaonkar 1990), Parker Hydrophilicity (Parker et al. 1986) and Bepipred 
Linear Epitope prediction (Larsen et al. 2006)).  
 
Table IV-1 Overview of the chlamydial strains used to construct the amino acid sequence alignment to 
identify C. suis-specific regions in the ProteinB and ProteinC sequences.  
ProteinB 
Species Strain Source 
C. suis 
H7, R16, R1, R33, H5, R19, S45, R24, 
130 Rogers, R27, R22, R28 
Deborah Dean, unpublished data 
C. psittaci 6BC Genbank* 
C. pecorum E58 Genbank* 
C. abortus S26/3 Genbank* 
C. trachomatis A/HAR-13 and 434/Bu  Genbank* 
   
ProteinC 
Species Strain Source 
C. suis S45 Deborah Dean, unpublished data 
C. psittaci 6BC Genbank* 
C. pecorum MC Marsbar Genbank* 
C. abortus S26/3 Genbank* 
C. trachomatis A/HAR-13 and 434/Bu Genbank* 
*The accession numbers of ProteinB and C are not disclosed in this thesis for reasons of confidentiality in view 
of valorization. 
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2.3.3. Pin ELISA 
2.3.3.1. Experimental Sera  
Pins were blocked with blocking buffer (0.01M PBS* [7.5 mM Na2HPO4, 145 mM NaCl, 
3.25mM NaH2PO4.2H2O; pH=7.2] supplemented with 0.1% Tween 20 and 5% BSA) for 3 
hours, at room temperature (RT) and 100 rpm. Subsequently, pins were washed three times 
(washing buffer [0.01M PBS*, 0.1% Tween 20], 10 min, 100 rpm). Sera were diluted in 
dilution buffer (0.01M PBS*, 3%BSA, 0.1% Tween 20) and incubated overnight at 4°C and 
100 rpm. After another washing step, pins were incubated in a 1000-fold dilution of 
polyclonal HRP conjugated anti-swine IgG (H+L) antibody (Bethyl Laboratories, 
Montgomery, USA) for 1 hour at room temperature and 100 rpm. After a final washing step, 
the optical density (OD) at 405 nm was measured upon addition of hydrogen peroxide and 
ABTS substrate (KPL, Gaithersburg, Maryland, USA). Stripping of the bound antibodies after 
measurement enabled re-use of the pin peptides. Therefore, pins were sonicated (70°C, 40 
kHz) for 1 hour in disrupt buffer solution (0.1M Na2HPO4.2H2O, 35 mM SDS, 0.1% 2-
mercapto-ethanol; pH 7.2) followed by 30 min sonication in ultra pure water. Pin peptides 
were stored at -20°C. For use in the pinELISA, experimental sera were diluted to the minimal 
concentration needed to exceed the positive cut-off value in the CT rMOMP ELISA. Thus, all 
experimental sera were used at approximately the same anti-chlamydial antibody 
concentration, to reduce false positive results due to background reading.  
2.3.3.2. Interpretation of data 
All data obtained with experimental sera were corrected for background signal using the 
values of the negative control serum. In order to find a C. suis specific antigen, peptides were 
selected for high OD-values for the anti-C. suis experimental sera and low OD-values for sera 
of animals infected/immunized with C. abortus, C. psittaci or C. pecorum. 
2.3.3.3. Field sera 
The pin ELISA protocol was slightly altered to test the set of ‘field sera’, obtained by 
sampling SPF-piglets and slaughter pigs (slaughterhouse). The blocking step was extended to 
an overnight incubation, and the sera were incubated for 1 hour at 37°C instead of at 4°C 
overnight. All field sera were tested in two dilutions: 1/100 and 1/500. The positive cut-off 
value was calculated as the mean of the OD values of negative control pigs sera plus twice the 
standard deviation and appeared to be 0.5. 
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3. Results 
3.1. In silico selection of C. suis specific peptides 
3.1.1. ProteinA 
The amino acid sequence alignments were used to search for the C. suis sequences with the 
highest divergence compared to C. trachomatis. Nine ‘C. suis specific regions’ were 
purchased as overlapping pin peptides (eight amino acids in length with a six residue overlap) 
for further in vitro specificity testing. 
3.1.2. ProteinB 
Similarly to the approach used for ProteinA, amino acid sequences were searched for C. suis 
specific regions, using alignments. The pairwise ProteinA sequence similarity among the 
considered C. suis strains varied from 76% to 100%. As expected, C. suis is among all species 
mostly related to C. trachomatis, with observed homology percentages ranging from 64 to 86 
%. The overall sequence similarity for the five considered chlamydial species varied from 59 
to 85 %.  
The multiple sequence alignment allowed the selection of a 52 amino acid region that is 
conserved among the considered C. suis strains and contains a high concentration of C. suis 
specific amino acid residues. In silico epitope prediction enabled the identification of an 
eight residue peptide (PeptideB), able to discriminate C. suis from the other chlamydial 
species occurring in pigs. However, it was unfeasible to select an antigenic ProteinB peptide 
to distinguish C. trachomatis from all available C. suis sequences. Therefore, PeptideB 
peptide is only valuable for serodiagnosis in pigs. PeptideB was purchased from pepscan 
(Lelystad, The Netherlands) in a pinELISA format for further in vitro specificity testing.  
3.1.3. ProteinC 
Alignment of all available C. trachomatis ProteinC sequences showed a high sequence 
conservation, with pairwise sequence identities ranging from 91 to 100%. When comparing 
the ProteinC sequences of C. suis S45 and C. trachomatis, on average 60% of the sequence is 
identical. The C. pecorum, C. psittaci and C. abortus ProteinC sequence showed on average 
33% sequence similarity to C. suis and C. trachomatis. The results of the protein sequence 
alignments, combined with epitope prediction, enabled the selection of the eight amino acid 
peptide (PeptideC).  
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3.1.4. In vitro selection of a ProteinA  
3.1.4.1. Optimization of experimental sera dilution 
The optimal dilution of the experimental sera for use in the pin ELISA, was determined by 
analysis of a two-fold dilution series in the CT rMOMP ELISA. The obtained optimal 
dilutions ranged from 1/3.5 to 1/896. More detailed results are represented in Table IV2.  
 
Table IV-2 The optimal dilution of the experimental sera based on the results of the 
C. trachomatis rMOMP ELISA. 
Species Strain Titer 
C. suis
#
 S45_1 1/224 
 S45_2 1/112 
 H7 1/3.5 
 R19 1/7 
C. abortus
#
 S26/3_1 1/100 
C. abortus* S26/3_2 1/896 
C. pecorum* 1710S 1/448 
C. psittaci
#
 98AV2129 1/857 
*: sera obtained after immunization; 
#
: sera obtained after infection 
 
3.1.4.2. ProteinA peptide ELISA with experimental sera 
The 152 ProteinA peptides were screened for sensitivity and specificity for C. suis with the 
experimental sera. One peptide, PeptideA, was selected based on maximal OD-values for 
C. suis antisera and minimal OD-values for C. abortus, C. psittaci and C. pecorum antisera.  
3.1.5. Specificity testing of PeptideB and C with experimental sera 
Both peptides showed no cross reaction to the C. abortus, C. pecorum and C. psittaci antisera. 
Moreover, all C. suis antisera clearly reacted to PeptideB with OD-values exceeding the cut-
off (0.5). However, for PeptideC, the OD values of the C. suis S45_1 and R19 antisera did not 
reach the cut-off. Therefore, the PeptideC was no longer considered as an antigen candidate 
and excluded from further experiments. 
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3.1.6. Validation of the Peptide A and B antigens 
3.1.6.1. Molecular characterization of field sera 
The field sera, sampled in the slaughterhouse, were molecularly characterized, using two 
tests. The presence of C. suis bacteria in the sampled pigs was detected by examination of 
rectal swabs using the C. suis specific real-time PCR. Bacterial DNA was detected in 69 of 83 
swabs. Furthermore, to detect anti-chlamydial antibodies, all sera were analyzed at a dilution 
of 1/100 using the CT rMOMP ELISA. Sixty-eight of 83 serum samples were positive. 
According to these results, the set of field samples originating from the slaughterhouse was 
divided in three groups: group A consisted of 64 sera originating from pigs that were positive 
in both real-time PCR and CT rMOMP ELISA, group B contained 9 sera and was subdivided 
in groups B1 and B2. The four sera of group B1 were sampled from PCR negative pigs and 
showed a clear response in the CT rMOMP ELISA. The five sera of group B2, sampled from 
PCR positive pigs, showed no response in the CT rMOMP ELISA. Group C comprises 10 
sera negative in both tests.  
3.1.6.2. Pin ELISA 
The sera of group A, B and C were used to validate the performance of the selected peptides 
for use in detection of anti-C. suis antibodies. An additional group (D) that contained sera of 
10 SPF-animals, served as an extra negative control group. All field samples were tested at 
dilutions 1/100 and 1/500. However, the majority of the OD-values of the 100-fold dilutions 
reached the upper detection limit of the used technology, possibly partly due to background 
reading. Therefore, field samples were tested in a 500-fold dilution in subsequent 
experiments. The cut-off value was calculated at 0.5. 
All sera of the negative control groups C and D were negative in the PeptideA and PeptideB 
ELISAs. In 50 of 64 sera of the positive control group A, antibodies for both peptides were 
demonstrated. Twelve sera contained anti-PeptideA antibodies, but no anti-PeptideB 
antibodies. The two remaining sera showed  no response for both candidate antigens. All sera 
of group B1 showed a clear response to both candidate peptides. For three (of five) sera of 
group B2, only anti-PeptideA antibodies were demonstrated. The remaining two (of five) sera 
showed no response to both candidate peptides. Table IV3 summarizes the obtained results 
of the field sera.  
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Table IV-3 Results of the C. suis real-time PCR, CT rMOMP ELISA and C. suis PeptideA and B ELISAs 
on 83 field sera. 
  Positive in 
Group Number Real-time 
PCR 
CT rMOMP 
ELISA 
PeptideB 
ELISA 
PeptideA 
ELISA 
A 64 64 64 50  [0.77±0.33] 62  [0.96±0.34] 
B1 4 0 4 4   [0.67±0.08] 4   [1.16±0.33] 
B2 5 5 0 0 3   [0.67± 0.15] 
C 10 0 0 0 0 
D 10 NP 0 0 0 
NP: not performed; The values of the average OD and associated standard deviations are respectively 
represented between brackets.  
  
Serodiagnosis of Chlamydia suis in pigs and humans 73 
 
4. Discussion 
The present study aimed to identify a C. suis specific and antigenic peptide for serodiagnostic 
use. Specific detection of anti-C. suis antibodies can provide the evidence for an existent 
infection in pigs and humans, an essential factor in the study of the zoonotic transfer of this 
microbe. Unfortunately, to date, no sensitive C. suis specific assay is available for animal or 
human serodiagnosis. In fact, seroprevalence studies in pigs are based on detection of 
antibodies against LPS, MOMP and whole EB preparations and serological cross-reactions 
with antibodies against other chlamydial species or other pathogens do occur (Schautteet and 
Vanrompay 2011). Specificity of an assay can be improved by using protein fragments or 
peptides instead of full length proteins, due to the reduced incidence of cross-reactions. 
However, direct coating via passive adsorption to the polystyrene surface of microplates in 
alkaline conditions is less efficient for peptide antigens compared to full length proteins. 
Nevertheless, several technical solutions, like synthesis of peptide-dextran conjugates (Bocher 
et al. 1997), the use of a streptavidin-biotinylated peptide system (Ivanov et al. 1992), or the 
use of a capture antibody (sandwich ELISA), have been developed to resolve these coating 
difficulties. Moreover, several peptide based ELISAs for chlamydiae are already developed 
and successfully used for serodiagnosis. Longbottom et al. applied a protein fragment of the 
Pmp90 protein of C. abortus (Longbottom et al. 2002). Furthermore, peptides of the MOMP 
variable domain IV are used as the antigen in commercially available ELISAs for 
C. trachomatis (Medac, Wedel, Germany). Since C. suis and C. trachomatis are 
phylogenetically closely related and the availability of C. suis sequence information is rather 
limited, the selection of a specific antigen is rather complex. Therefore, the present study 
focused on the identification of eight-aminoacid peptide antigens to minimize cross-reactions 
to other pathogens. Based on the literature on antigen discovery in C. trachomatis , C. abortus  
and C. suis , three candidate proteins were chosen for screening for a C. suis specific antigen. 
Although the in silico analysis of the C. suis ProteinA and C was based on the sequences of 
only two strains (S45 and MD56 respectively), the in vitro screening was executed with sera 
of pigs infected with H7, S45 and R19 to compensate for this in silico limitation. Hence, the 
methodology screens for representative peptide antigens for all used C. suis strains and led to 
the selection of three peptides for further testing using experimentally generated positive and 
negative control sera.  
The quality of the two remaining peptides was assessed using molecularly characterized pig 
sera. Real-time PCR of rectal swabs and an ELISA based on the full length recombinant 
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MOMP of C. trachomatis, were used to create four control groups of sera. The real-time PCR 
enabled the sensitive and specific detection of C. suis bacteria (De Puysseleyr et al. 2014b). 
Recombinant MOMP based detection of anti-chlamydial antibodies has been applied 
successfully in several former studies (Vanrompay et al. 2004; Verminnen et al. 2006; 
Schautteet et al. 2011). All sera of the negative control groups C and D were negative in the 
PeptideA and B ELISAs. The absence of reactivity of negative control sera supports the 
specificity of the peptides for serodiagnosis of C. suis.  
The high reaction rate of the positive control sera of group A confirms the antigenicity of both 
peptides. Furthermore, twelve positive control sera contained anti-PeptideA, but no anti-
PeptideB antibodies, suggesting the PeptideA antigen performs better in terms of sensitivity. 
However, two sera from pigs that reacted  positive in real-time PCR and CT rMOMP ELISA, 
showed no response for both candidate antigens. These false negative observations could be 
attributed to an inability of the peptide antigens to detect certain C. suis strains. However, 
false positive results of the CT rMOMP ELISA could have caused the incorrect assessment of 
the two sera as true positives. After all, cross-reaction with other pathogens is common when 
using full length proteins as antigens (Schautteet and Vanrompay 2011). Nevertheless, since 
the CT rMOMP ELISA is a family-specific assay, also antibodies produced in response to 
infections with other chlamydial species, are detected. In fact, mixed  infections of chlamydial 
species may occur in pigs (Szeredi et al. 1996; Hoelzle et al. 2000). Additional analysis of the 
used sera to detect the presence of antibodies to different antigens of other chlamydial species 
might clarify the real nature of the negative result of these two positive control sera.  
Group B contained sera from pigs that were negative in PCR, but positive in the CT rMOMP 
ELISA (B1) or vice versa (B2). All four sera of group B1 showed a clear response to both 
peptides. In fact, this may indicate a prior infection since antibodies were present, but no 
bacteria could be demonstrated. The five samples assembled in group B2 were derived from 
PCR positive pigs, but contained no anti-CT rMOMP antibodies. All five sera were negative 
in the PeptideB ELISA, however, anti-PeptideA antibodies were demonstrated in three sera. 
This observation is consistent with a higher sensitivity of PeptideA compared to PeptideB 
when testing positive control sera, especially since equal amounts of both antigens were used. 
In general, the peptide ELISAs seem to be more sensitive compared to the CT rMOMP 
ELISA, however, it should be mentioned that the total amount of antigen used in the pin 
ELISA assays is rather high (100µg), especially compared to cell lysates containing 
recombinantly produced MOMP. Yet, full length proteins are considered to be far more 
antigenic than peptides. The remaining two (of five) sera of group B2 showed no response to 
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both candidate peptides, possibly due to a very limited or absent antibody response in the 
pigs.  
In summary, analysis of the experimental sera and molecularly characterized field sera 
demonstrated the suitability of the PeptideA and B antigens for use in serodiagnosis of C. suis 
in swine. Moreover, PeptideA appeared more sensitive compared to PeptideB, and PeptideA 
is as well promising for development of an assay for serodiagnosis in humans. However, the 
set of experimental sera, used for preliminary specificity screening did not include a 
C. trachomatis antiserum. Therefore, the specificity of the antigens for C. suis remains to be 
confirmed using C. trachomatis antisera. Furthermore, optimization of the used reagents, 
including antigen concentration and serum and secondary antibody dilutions, are required. In 
addition, the performance of the ELISA test, such as the sensitivity and specificity, needs to 
be evaluated using a larger set of negative and positive control sera, in order to validate the 
assay.  
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Significance of chlamydiae in pigs 
Chlamydiae are widespread in farmed pigs throughout the world (Schautteet and Vanrompay 
2011) and are found in wild boars (Di Francesco et al. 2011). Chlamydia suis is the most 
prevalent species and its primary pathogenicity for the respiratory system, the gastrointestinal 
tract, the conjunctiva and the urogenital tract has been proven by several experimental 
infections in gnotobiotic and conventionally raised pigs (Rogers and Andersen 1996; Rogers 
et al. 1996; Rogers and Andersen 1999, 2000; Sachse et al. 2004; Reinhold et al. 2008b; 
Guscetti et al. 2009a; Pospischil et al. 2009b; Reinhold et al. 2010; De Clercq et al. 2014). 
Additionally, chlamydial infections may lead to economical losses in commercial pigs due to 
arthritis, pericarditis, polyserositis, pneumonia, conjunctivitis, enteritis, diarrhea and 
reproductive failure (Willigan and Beamer 1955; Sarma et al. 1983; Woollen et al. 1990; 
Zahn et al. 1995; Andersen and Rogers 1998; Eggemann et al. 2000). Although C. suis is 
endemic in pigs, a significant part of the infections are asymptomatic (Hoelzle et al. 2000; 
Camenisch et al. 2004; Englund et al. 2012). Chlamydiae are still considered of minor 
importance in commercial pigs and are relatively unknown swine pathogens. Therefore, the 
available funding to investigate these apparently less important infections is limited. Besides, 
a number of other considerations might complicate the evaluation of the significance of 
chlamydiae for pig production. Firstly, the ecomomical impact of chlamydial infections on 
pig production has not been demonstrated so far. Consequently, the required evidence of the 
significance of chlamydiae to swine health is lacking. Studies comparing the economic yield 
of pigs protected against chlamydial infections, for instance through vaccination, and 
untreated swine, might clarify the consequences on growth, mortality and reproduction. 
However, efficient vaccines or alternative protection mechanisms are not available. Moreover, 
the discrimination of vaccinated and naturally infected swine may be challenging. Secondly, 
several cases of the appearance of pathology due to synergistic interactions with other 
common pathogens of pigs have been reported. This phenomenon was already observed for 
Salmonella, Porcine circovirus type 2 (PCV-2) and Acanthamoebae (Pospischil and Wood 
1987; Carrasco et al. 2000; Becker et al. 2007; Schautteet et al. 2010). In fact, both pathogens 
can be present in healthy pig herds, but might trigger each other’s pathology. Consequently, 
the involvement of chlamydiae in the observed pathology may be masked by the presence of 
other, commonly known swine pathogens. Nevertheless, even if the pathogenicity of 
chlamydiae is less severe compared to other well known swine pathogens like Mycoplasma 
hyopneumoniae and PCV-2, pig health might benefit from increasing awareness of 
veterinarians. 
80  Chapter V 
 
Spread of C. suis in pigs 
Numerous studies demonstrate a high prevalence of chlamydial species in the intestines of 
clinically healthy and diseased pigs, suggesting the porcine intestinal tract to be the natural 
habitat for chlamydial species (Schiller et al. 1997a; Hoelzle et al. 2000). Yet, C. suis is 
considered to be the most prevalent, as was also confirmed in Chapter III. The intestines may 
function as a reservoir from where the pathogen can spread to other organs and animals 
(Nietfeld et al. 1993). Urogenital chlamydiosis may result from fecal contamination of the 
vagina (Hoelzle et al. 2000; Yeruva et al. 2013). This hypothesis is supported by the ability of 
the C. suis strain S45, originally isolated from the intestines of an asymptomatic piglet, to 
cause pathology in the urogenital tract of pigs (De Clercq et al. 2014). Furrowing in feces of 
chlamydiae-shedding animals may yield eye-, respiratory- and gastro-intestinal infections. In 
addition, C. suis has been detected in the semen of boars, suggesting potential venereal 
transmission during mating or artificial insemination (Kauffold et al. 2006; Teankum et al. 
2006; Schautteet et al. 2013). Systematic screening of semen in insemination centers could be 
useful to monitor the spread of C. suis and might clarify if measures are needed to prevent 
spread of infections through international trade of boar sperm.  
 
Tetracycline resistance in C. suis 
Another issue that contributes to the significance of chlamydial infections in swine is the 
emergence of antibiotic resistance genes. Chlamydiae are generally highly sensitive to the 
relatively inexpensive broad spectrum Tc antibiotics. However, Tc
R
 C. suis strains have been 
appearing in the U.S. and European pig industry (Andersen and Rogers 1998; Di Francesco et 
al. 2008; Borel et al. 2012; Schautteet et al. 2013). Borel et al. (2012) suggested that the rapid 
selection for Tc
R
 C. suis strains observed after treatment of conjunctivitis and diarrhea with 
Tc, was facilitated by close contact of the pigs. Therefore, the recent implementation plan of 
the European Commission on group housing of sows and gilts (Directive 2008/120/EC on the 
protection of pigs) might contribute to the increasing prevalence of Tc
R
 C. suis strains in 
European pigs. The C. suis Tc
R
 phenotype is attributed to the stable integration of the Tc 
resistance gene tet(C) into the chlamydial chromosome (Dugan et al. 2004). In chapter III, 
rectal swabs of slaughtering pigs from 10 different farms were examined for the presence of 
C. suis strains. Fifteen C. suis isolates were obtained, whereof three contained the tet(C) gene. 
These results confirm the presence of the Tc
 
resistance gene in the Belgian pig population, as 
was equally demonstrated by Schautteet et al. (2013). This study reported the presence of the 
tet(C) resistance gene in swine suffering from severe reproductive disorders and failure of 
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antibiotic treatment. Our study did not comprise information concerning the health status and 
possible failure of antibiotic treatment of the animals sampled in the slaughterhouse (Chapter 
III). Although the presence of the tet(C) gene was always associated with a Tc
R
 phenotype in 
American and Italian C. suis strains (Andersen and Rogers 1998; Di Francesco et al. 2008), it 
would be interesting to determine the minimal inhibitory concentration (MIC) values for the 
isolated strains to support the significance of the obtained results. This in vitro antimicrobial 
susceptibility testing procedure is based on the minimal concentration of the antimicrobial 
needed to affect the size and morphology of 90% of the inclusions, and may be used to 
address phenotypical resistance (Suchland et al. 2003). Alternatively, a reverse transcriptase 
PCR based method has been described which enables a more sensitive and specific MIC 
quantification (Cross et al. 1999). However, it should be mentioned that the in vitro MIC may 
not necessarily correlate with the in vivo value. Indeed, experimental conditions like the cell 
line and culture media, have a notable influence on the success of inclusion forming and 
antimicrobial penetration. Moreover, the influence of the immune clearance mechanisms is 
not taken into account in the in vitro system.  
The presence of C. suis isolates with and without the tet(C) gene in animals raised on the 
same farm might also indicate the circulation of different strains in a pig herd. In this respect, 
it would be interesting to investigate the genetic diversity of C. suis bacteria on herd level. 
Multi-locus sequence typing (MLST) has successfully been used to study population biology 
(Maiden et al. 1998; Liang et al. 2013) and might also be very useful as genotyping method 
for the fastidious micro-organism C. suis, since this technique allows culture-independent 
strain typing. The MLST approach is based on the sequencing of internal fragments of 
multiple housekeeping genes. The observed combination of housekeeping-alleles defines the 
allelic profile or sequence type (ST). It would be interesting to study the correlation between 
the STs and pathologies observed in pigs. Furthermore, this approach could provide insights 
in the spread of the C. suis in the pig population on herd level or beyond.  
 
Zoonotic potential of C. suis 
The two chlamydial species C. psittaci and C. abortus are well described agents of zoonotic 
infections. Chlamydia psittaci is transferred from birds to humans through aerosols, and 
infections can vary from apparently asymptomatic to severe pneumonia. Moreover, 
Chlamydia abortus infections in pregnant women, resulting from exposure to infected sheep 
and goats, can result in miscarriages and stillbirths (Buxton 1986; Kampinga et al. 2000b; 
Pospischil et al. 2002b; Walder et al. 2003; Meijer et al. 2004a; Walder et al. 2005a). 
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Chlamydia suis is phylogenetically highly related to the human pathogen C. trachomatis 
(Everett et al. 1999b) and therefore, its zoonotic potential has been suggested. However, if 
C. suis is transferred from pigs to humans, the significance of these events, and hence the 
necessary preventive measures, are largely dependent on the probability and the clinical 
consequences of potential infections. To address these issues, four parameters need to be 
studied: presence of a source/reservoir of bacteria, release of the pathogen in the environment, 
exposure of humans and the appearance of (clinical) consequences. If zoonotic transmission 
actually occurs, persons who are in daily contact with live pigs, like pig farmers or 
slaughterhouse employees, are the most likely subjects for transfer. Therefore, the presence 
and zoonotic transmission of C. suis were evaluated in a Belgian slaughterhouse, as described 
in Chapter III. The presence of C. suis was confirmed for 52% of the sampled animals, with 
positives on all 10 sampled farms. Thus, slaughter pigs are indeed a reservoir of C. suis 
bacteria and the abattoir is a confirmed environment to study the associated potential risk. 
Analysis of the contact surfaces and air allowed us to address the release of bacteria and 
exposure of the employees to C. suis. Indeed, air and contact surfaces seemed to be a source 
of viable C. suis bacteria, albeit only in limited amounts. Compared to a study on the zoonotic 
transfer of C. psittaci in a chicken and turkey slaughterhouse (Dickx et al. 2010), the amount 
of released C. suis bacteria seems to be smaller, suggesting a smaller infection pressure. 
However, this assumption needs further confirmatory examination in additional abattoirs to 
clarify the significance of bacterial spreading. The main finding of chapter III is the isolation 
of viable C. suis bacteria from ocular swabs of two employees. These results represent 
presumptive evidence supporting the zoonotic transfer hypothesis, in addition to the 
identification of single and mixed infections of C. suis and C. trachomatis as the cause of 
trachoma in patients in Nepal (Dean et al. 2013b). In addition, recent unpublished result of 
our lab, which are not part of this thesis, provided us with three additional pharyngeal and 
rectal C. suis isolates originating from nine Belgian pig farmers. In contrast to the Nepal case, 
the presence of C. suis was not linked to the appearance of clinical symptoms in the infected 
persons in our studies. Thus, the clinical consequences of zoonotic transfer of C. suis appear 
limited, certainly compared to other known zoonoses like C. psittaci, able to cause a 
respiratory infection that may be fatal if untreated (Kovacova et al. 2007), or Salmonella 
species, causing intestinal illness or even osteomyelitis, bacteremia or meningitis (Parry 
2003). However, additional studies are certainly required to clarify possible clinical effects 
before zoonotic transfer of C. suis is considered to be less important.  
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The associated risk of confirmed zoonotic pathogens for persons that are handling pigs during 
their professional activities can be managed at different levels. The first level aims to 
eliminate the exposure to and infection from zoonotic pathogens. This could be achieved by 
combating animal infections on the one hand, and by limiting the emission (shedding) of 
viable bacteria in the environment, through reduction of the stress level experienced by the 
animals, on the other hand. Screening of stock using bacteriological monitoring or serology to 
trace infections is applied for some pathogens, such as Salmonella (Mousing et al. 1997). In 
this context, the use of antibiotics to deal with such infections should be avoided since major 
concern is associated with emerging antibiotic resistance genes, especially in the case of 
chlamydiae, and C. suis in particular. Alternatively, an effective vaccine is of greater value to 
reduce the prevalence of the concerned pathogen. Besides efforts to eliminate the source of 
infections, collective and personal protective measures are often applied to reduce the 
remaining exposure to harmless level. These range from general practices and procedures, 
such as ventilation in case of airborne pathogens, special waste collection and disposal or 
safety and warning signs, to more personal precautionary measures, including hand hygiene 
and protective equipment such as gloves, eyewear and masks. However, monitoring and 
management strategies involve a considerable effort and cost. Therefore, further prior studies 
are needed to clarify the economical consequences to pig production and zoonotic importance 
of C. suis to justify implication of precautionary measures.  
 
The potential zoonotic character of C. suis is also important in the context of the appearance 
of Tc
R
 strains in farming pigs. Emergence of drug resistance, even to new classes of 
antimicrobials, poses a challenge for treatment of patients in healthcare settings (Bassetti et al. 
2011). Tetracycline and its derivatives are critical therapeutic agents in the fight against 
C. trachomatis, a pathogen of significant importance to human patients, particularly in the 
developing world. Indeed, ocular strains cause active trachoma affecting an estimated 84 
million people, of whom about 1.3 million are blind (Mabey 2008). Furthermore, 
C. trachomatis infection is the most common bacterial sexually transmitted disease in the 
world (WHO 2008). The main concern is attributed to the possibility of the introduction and 
spread of the tet(C) gene, originating from C. suis strains circulating in the swine population, 
to C. trachomatis strains, and this would impede treatment and control of infections. Some 
former studies attempted to bring some clarity on the probability of this event. 
Lenart et al. (2001) showed that the two biologically distinct chlamydial strains C. suis R19 
and C. trachomatis L2 could develop within a single inclusion after sequential in vitro 
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infection, creating an environment where the two strains can interact. This event observed in 
vitro might also occur in vivo if Tc
R
 C. suis strains are transferred to C. trachomatis infected 
persons. Interestingly, Dean et al. (2013b) demonstrated mixed infections of C. suis and 
C. trachomatis as the cause of trachoma in two patients in Nepal. In addition, we isolated 
C. suis from the eyes of two slaughterhouse employees (Chapter III). Thus, the eye might act 
as a niche where both strains interact. Moreover, Suchland et al. (2009) demonstrated the in 
vitro transfer of a Tc resistance gene from C. suis S45 to C. trachomatis L2. Therefore, in vivo 
exchange of antibiotic resistance genes and consequent emergence of Tc
R
 C. trachomatis 
strains is believed to be plausible. No stable antibiotic resistance, leading to treatment failure, 
has been reported in C. trachomatis isolates from human patients. However, Suchland et al. 
(2009) hypothesized that the entry of the tet(C) island into the C. suis genome was more 
challenging, and transfer among strains, and even species, is more straightforward and 
certainly not unlikely.  
If allowed by the government, the fluoroquinolone antibiotic enrofloxacine is currently being 
used to reduce the economic loss due to Tc
R
 C. suis outbreaks in pigs. However, 
fluoroquinolones are used extensively in human medicine and agricultural use of these drugs 
may increase selection of antibiotic resistance in bacteria (Knudsen 2001). Indeed, some of 
the first C. suis strains, stably-resistant to Tc, isolated from diseased and normal pigs, were 
actually doubly-resistant, also exhibiting a stable resistance to sulfadiazine (Andersen and 
Rogers 1998). New Tc analogs which are immune to Tc resistance protection mechanism, and 
new agents belonging to completely new classes of antimicrobials, are regularly examined. 
However, clinical examination of these compounds takes years and emergence and spread of 
antibiotic resistance genes occurs rapidly, turning back the clock to preantibiotic era (Roberts 
1996). If bacterial strains are present in the animals, even asymptomatically or in very low 
numbers, they are subjected to the selective pressure of any administered antibiotic treatment. 
Therefore, antimicrobials should be used in a responsible way and the emergence and spread 
of antibiotic resistance in life stock should be monitored.  
 
Role of diagnostic performance  
Additionally, some considerations concerning the performance of the available diagnostics 
need to be mentioned. Sandoz and Rockey (2010) state that the lack of genetic evidence of 
antibiotic resistance leading to treatment failures in humans may be a consequence of 
insufficiency of the current diagnostic methods. Culture was considered as the ‘gold standard’ 
for chlamydial diagnosis. However, isolation of clinical strains can be extremely challenging, 
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particularly in the case of the heterogenic species C. suis. Many different cell lines are used in 
different diagnostic laboratories and there is no universal testing methodology, although 
McCoy, BGM, Vero or Hela cells are most often used (Sachse et al. 2009). No difference in 
isolation performance was observed between the McCoy and Vero cells during culture 
analysis of the slaughterhouse employee samples (Chapter II versus Chapter III). Culture 
recovery rate is particularly low for rectal samples (Schachter et al. 2008). However, the 
intestines are the most promising sampling site in terms of the number of present bacteria, 
since they presumably function as a reservoir for C. suis. Although culture remains essential 
for isolation and propagation of viable chlamydiae and the specificity approaches 100%, it is a 
time-consuming technique requiring technical expertise and its sensitivity is often marginal. 
Moreover, additional DNA based assays need to be performed on the isolated bacteria to 
identify the involved species. Therefore, more and more NAATs are developed and optimized 
to allow direct analyses on matrices such as swabs or organs, without the need for prior 
cultivation. The 20-30% higher sensitivity of NAATs and the short performance time are 
important advantages of this technique over culture. Moreover, the success of DNA detection 
does not rely on the viability of the diagnosed organisms and thus, less stringent sample 
transport conditions are required. However, additional diagnostics, such as isolation, are thus 
still necessary to confirm the viability of the organisms. Moreover, the false positive rate, 
predominantly caused by contamination, can be considerable and the reproducibility is often 
low. Moreover, also false-negative results are an important concern. In addition to the 
presence of inhibitory substances and the occasional failure of DNA extraction procedures, 
emergence of sequence variation may cause a false negative outcome. The primer and/or 
probe target sequences need to be conserved across different target strains or organisms. 
Therefore, the number of available sequences in nucleotide databases and the appearance of 
mutations or new strains strongly influence the performance of NAATs. In this respect, 
targeting multiple genes may be useful to reduce the occurrence of sequence-related false 
negative results. 
Moreover, the choice of the applied molecular-based diagnostics is biased by our 
understanding of particular species and strains involved in disease pathologies. Not all species 
are routinely screened for and uncommon infections might be missed. Indeed, many ocular 
C. trachomatis manifestations were actually mixed infections with C. pneumoniae, C. suis 
and/or C. psittaci in a trachoma-endemic region of Nepal (Dean et al. 2008). These technical 
issues present significant challenges in evaluating the zoonotic potential of chlamydial strains 
and emergence of antibiotic resistance (Sandoz and Rockey 2010).  
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Apart from molecular tests aiming at direct detection of the involved bacteria, serological 
tests can be helpful. Antibody detection is often applied to diagnose infections on herd or 
individual animal level, for instance during epidemiology studies. However, animals do not 
always produce antibodies immediately upon infection and the absence of an antibody 
response is thus not always correlated to the absence of infection. Moreover, the produced 
antibodies remain present in the serum for a long period after clearance of the infection. 
Therefore, detection of antibodies may indicate a present or past infection. Nevertheless, 
analysis of samples of different time-points enables detection of disease outbreaks, reflected 
as antibody titer changes. This principle is often applied during animal health monitoring 
programs. Reports on the serological prevalence of chlamydial infections in swine are 
generally based on detection on Chlamydiaceae family level, and do not allow identification 
of the involved species. Although family specific detection of antibodies is useful to study the 
epidemiology, in some cases, a C. suis specific assay would be even more informative. 
Indeed, a specific antibody test would enable C. suis specific epidemiology and the 
discrimination of C. suis from other chlamydial species in human individuals, as supporting 
evidence of a zoonotic infection. Therefore, Chapter IV aimed to select antigenic peptides for 
serodiagnostic use. Specificity of an assay can be improved by using protein fragments or 
peptides instead of full length proteins, due to the reduced incidence of cross-reactions. 
Despite the lower efficiency of the passive adsorption of peptides to carrier surfaces, several 
peptide based ELISAs for chlamydiae are already developed and successfully used for 
serodiagnosis (Longbottom et al. 2002). Based on the literature on antigen discovery in 
C. trachomatis , C. abortus and C. suis , three candidate proteins were chosen for screening 
for a C. suis specific antigen. Analysis of experimental and molecularly characterized field 
sera allowed selection of a two peptide antigens for serodiagnostic use on swine sera. Prior in 
silico peptide selection included C. trachomatis protein sequences to rule out cross-reactions. 
However the set of used experimental sera did not contain C. trachomatis positive control 
sera. Still, it would be beneficial to verify the absence of cross-reactions of the selected 
peptides with C. trachomatis to confirm the suitability of these antigens for diagnosis of 
C. suis infections and zoonotic transfer in human sera. Without doubt, validation of 
serological assays does not only involve the selection of suitable antigens, as reported in 
Chapter III. Additionally, the concentrations or dilutions of the antigen adsorbed to the plate, 
serum, enzyme-antibody conjugate and substrate solution need to be optimized, to achieve 
minimal background activity and maximal spread in activity between negative and high 
positive samples. These optimization is performed using checkerboard titrations of each 
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reagent against all others. Furthermore, additional determination of the optimal temporal, 
physical and chemical variables, like the pH and composition of the diluents, washing and 
blocking buffers or even the used equipment, might further improve the performance of the 
assay. Apart from the protocol optimization, the assessment of the reproducibility, 
repeatability, accuracy and the analytical sensitivity and specificity are also necessary steps in 
the assay development and validation. The repeatability is the agreement between replicates 
within and between runs of the assay, and can be addressed by evaluation of the results from 
replicates analyzed on the same plate, different plates, and distinct days. Similarly, the 
reproducibility is associated with the degree of concordance of the results obtained with the 
identical assay performed in different laboratories. The accuracy is the amount of agreement 
between the test value and the expected value for an analyte in a standard sample of known 
activity in each run of the assay. This parameter can be assessed by inclusion of a standard 
sample for which the titer is determined with an independent method. The analytical 
sensitivity is related to the ability of the assay to assess infected animals as ‘positive’, and is 
determined using a panel of at least 300 sera from reference individuals having known history 
and infection status relative to the concerning disease. The specificity, related to the amount 
of false positives, is addressed with sera of known uninfected reference individuals and 
requires even more samples, since more biological variables may contribute to false positive 
results (Jacobson 1998). However, for endemic infections, it is almost impossible to find a 
large number of proven uninfected individuals, as is the case for chlamydiae in pigs. 
Consequently, relatively small panels of sera are used, rendering less precise estimations. 
Therefore, it is recommended to obtain confirmatory data to update the estimated sensitivity 
and specificity once the concerning assay is routinely used.  
 
Future Perspectives 
To fully understand the consequences and risk factors associated with chlamydiaceae 
infections in swine, further investigation is needed on farms and throughout production and 
processing systems. The primary pathogenicity of C. suis is proven in several experimental 
infections and several studies report the involvement of chlamydiae in disease in commercial 
pigs. However, additional experiments addressing the overall economical impact of 
chlamydiae on pig production are needed to elucidate the real importance of these infections, 
and suggest the justified and required measures to prevent spread of infections. In this 
context, it should be mentioned that bacteria are under constant evolutionary pressure and 
their epidemiology and virulence may change over time. Therefore, monitoring of these 
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changes is necessary to observe effects on the associated health complications. Similarly, the 
evolution of bacterial strains might also influence the performance characteristics of validated 
diagnostic measures and monitoring of test performance is recommended.  
Chlamydia suis is a heterogeneous species and its strain diversity might explain the variance 
in observed clinical symptoms. Research on a potential link between the causative strain and 
the appearing pathology might provide insight into the actual trigger to disease. The first full 
genome sequence for C. suis, the MD56 strain isolated in Italy, was only recently made public 
(Donati et al. 2014), but additional genome sequences could be useful to address these issues. 
In addition, kinetic studies to follow the route of infection and clinical manifestations in pigs 
from birth to slaughter may gain comprehensive knowlegde about the chlamydial infection 
biology in pigs. Moreover, it would be interesting to investigate the genetic susceptibility of 
various pig breeds to C. suis-associated disease, since breed-dependent susceptibility was 
observed for pseudorabies virus (Reiner et al. 2002b), porcine reproductive and respiratory 
syndrome virus (PRRSV) (Halbur et al. 1998), E. coli (Duchet-Suchaux et al. 1991; Michaels 
et al. 1994), and Sarcocystis miescheriana (Reiner et al. 2002a).  
Considering the emerging Tc resistance in C. suis and the possible associated public health 
concerns, future research should also focus on confirmation of the zoonotic transmission and 
significance of C. suis infections in larger human risk populations. Detection of DNA, viable 
bacteria and mucosal antibodies may provide conclusive evidence of zoonotic transfer and 
eye infections caused by C. suis in humans. In addition, also monitoring of Tc
R
 C. suis in pig 
farming and efforts to restrict the use of Tc in the veterinary field are advisable. The 
development of alternative treatments, which target virulence traits instead of killing bacteria, 
leading to a lower selective pressure compared to conventional antibiotics, might provide a 
solution. Promising compounds have already been described, for instance transferrins 
(Beeckman et al. 2007; Van Droogenbroeck et al. 2008; Van Droogenbroeck et al. 2011). 
Moreover, research on the prevention of infection through vaccination should be promoted. 
The ideal veterinary vaccine is inexpensive, safe, genetically and physically stable, suitable 
for industrial mass application and induces long-term heterotypic protective immune 
responses with a single dose (Littel-van den Hurk et al. 2000). Genital infection of pigs with 
C. suis S45 elicits both cellular and humoral immune responses and provides a certain level of 
protection against re-infection, suggesting that vaccination of pigs might provide the intended 
protection (De Clercq et al. 2014).  
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Summary 
Chlamydiaceae are Gram-negative obligate-intracellular bacteria that cause a variety of 
diseases in humans and animals. Chlamydiaceae infections are widespread in commercial 
pigs and cause important economic losses in pig production. This thesis focuses on 
Chlamydia (C.) suis, the most prevalent chlamydial species occurring in pigs, and considered 
as endemic in the intestines of domestic swine (Schautteet and Vanrompay 2011). Its primary 
pathogenicity is proven by several experimental infections in gnotobiotic pigs (Rogers et al. 
1996; Rogers and Andersen 1999, 2000; Reinhold et al. 2008a; Guscetti et al. 2009b; 
Pospischil et al. 2009b; Reinhold et al. 2010). Infections are mainly associated with 
respiratory disease, enteritis, periparturient dysgalactiae syndrome, conjunctivitis and 
reproductive failure (Sarma et al. 1983; Woollen et al. 1990; Rogers and Andersen 1996; 
Schiller et al. 1997b; Rogers and Andersen 1999; Eggemann et al. 2000; Kauffold et al. 2006; 
Reinhold et al. 2008b; Guscetti et al. 2009a; Schautteet et al. 2013). Chlamydiae are generally 
highly sensitive to the relatively inexpensive Tc antibiotics. However, Tc
R
 C. suis strains have 
been appearing in the U.S. and European pig industry (Andersen and Rogers 1998; Di 
Francesco et al. 2008; Borel et al. 2012; Schautteet et al. 2013). Besides the economic impact 
on pig production due to treatment failure, Tc
R
 C. suis strains pose an additional risk for 
human health. Chlamydia suis is phylogenetically closely related to the human pathogenic 
species Chlamydia (C.) trachomatis (Everett et al. 1999b) and is, for this reason, believed to 
be a zoonotic bacteria. Zoonotic transmission of C. suis might enable transfer of the Tc 
resistance gene to the human pathogenic species C. trachomatis, affecting millions of people 
worldwide (Mabey 2008; WHO 2008). Monitoring the spread of Tc
R
 C. suis into commercial 
pigs and the zoonotic transmission to humans is needed to assess the associated risk and to 
decide on the appropriate measures. For this purpose, reliable C. suis-specific molecular and 
serological tests to detect C. suis bacteria and anti-C. suis antibodies in animal and human 
specimen and sera, are indispensable. 
Chapter I, gives a brief overview of the history, taxonomy and biology of chlamydial 
infections, followed by a short introduction to chlamydial effector proteins and the chlamydial 
outer membrane complex. Furthermore, the occurrence of Chlamydiaceae species in pigs is 
described with a focus on the diagnosis, epidemiology, pathology, antibiotic resistant 
properties and zoonotic potential of C. suis. 
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In Chapter II, we developed a sensitive and specific TaqMan probe-based C. suis real-time 
PCR to examine clinical samples of both pigs and humans. The analytical sensitivity of the 
real-time PCR is 10 rDNA copies/reaction without cross-amplification with DNA of other 
Chlamydia species. The PCR was successfully validated using conjunctival, pharyngeal and 
stool samples of pig handlers, as well as porcine samples from two farms with evidence of 
reproductive failure and one farm without clinical disease. The assay can be applied for 
detection of C. suis strains in pigs and to examine their zoonotic potential more extensively. 
Additionally, the real-time PCR could be useful to monitor and prevent the spread of C. suis 
strains, for instance through international trade of boars and sperm. 
In Chapter III, we assessed the presence of C. suis in pigs, contact surfaces, air and 
employees in a pig slaughterhouse using isolation of chlamydial organisms in cell culture and 
the real-time PCR, developed in chapter II. Furthermore, C. suis isolates were tested for the 
presence of the tet(C) gene. Chlamydia suis bacteria could be demonstrated in samples from 
pigs, the air and contact surfaces. Moreover, eye swabs of two employees were positive for 
C. suis by both PCR and culture. The tet(C) gene was absent in both human C. suis isolates. 
The employees showed no clinical signs and were negative for C. trachomatis. However, the 
adaptive ability of C. suis to acquire the tet(C) gene, especially when exposed to selective 
pressure, and the possibility of C. suis transfer to humans could have far-reaching 
consequences for public health. These findings emphasize the need for further 
epidemiological and clinical research to elucidate the significance of human ocular C. suis 
infections.  
In Chapter IV, we identified antigenic and C. suis specific peptide epitopes for 
serodiagnostic use. Protein sequences of three candidate proteins of the chlamydial species 
prevalent in pigs and humans, were aligned to select C. suis specific peptides. Sequence 
alignments and software-based antigenicity analysis were combined with the in vitro 
screening using a panel of control sera of pigs. The use of an additional set of molecularly-
characterized field sera demonstrated the suitability of the PeptideA and B antigens for use in 
serodiagnosis of C. suis in swine. Moreover, PeptideA appeared more sensitive compared to 
PeptideB. Although further optimization of the assay is required and the specificity of the 
antigens for C. suis remains to be confirmed using C. trachomatis antisera, PeptideA is 
promising for development of an assay for serodiagnosis in humans.  
Finally, Chapter V describes our conclusions and perspectives for further research. 
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Samenvatting 
De familie van de Chlamydiaceae zijn Gram-negatieve, obligaat intracellulaire bacteriën die 
verscheidene ziekten veroorzaken in mens en dier. De Chlamydiaceae zijn wijdverspreid in de 
varkenshouderij en zijn verantwoordelijk voor aanzienlijke economische verliezen. In deze 
thesis werd de focus gelegd op Chlamydia (C.) suis, het meest voorkomende Chlamydia 
species bij varkens, dat bovendien als endemisch beschouwd wordt in de intestinale flora van 
varkens (Schautteet and Vanrompay 2011). De primaire pathogeniciteit van C. suis werd 
reeds aangetoond in verscheidene experimentele infectie proeven in gnotobiotische varkens 
(Rogers et al. 1996; Rogers and Andersen 1999, 2000; Reinhold et al. 2008a; Guscetti et al. 
2009b; Pospischil et al. 2009b; Reinhold et al. 2010). Infecties zijn voornamelijk geassocieerd 
met respiratoire aandoeningen, entiritis, periparturient dygalactiae syndroom, conjunctivitis en 
reproductiestoornissen (Sarma et al. 1983; Woollen et al. 1990; Rogers and Andersen 1996; 
Schiller et al. 1997b; Rogers and Andersen 1999; Eggemann et al. 2000; Kauffold et al. 2006; 
Reinhold et al. 2008b; Guscetti et al. 2009a; Schautteet et al. 2013). Chlamydiae zijn 
doorgaans erg gevoelig voor het relatief goedkope Tc antibioticum. In de V.S. en Europa 
duiken echter steeds meer Tc resistente Chlamydia suis stammen op (Andersen and Rogers 
1998; Di Francesco et al. 2008; Borel et al. 2012; Schautteet et al. 2013). Naast de 
economische impact in de varkenshouderij, vormen de Tc
R
 C. suis stammen bovendien ook 
een risico voor de volksgezondheid. Chlamydia suis is immers fylogenetisch nauw verwant 
met het menselijke pathogene species Chlamydia trachomatis (Everett et al. 1999b), en wordt 
hierdoor als een potentieel zoonotisch bacterie aanzien. De zoonotische transfer van 
Chlamydia suis zou bovendien de transfer van het Tc
R
 gen naar C. trachomatis mogelijk 
maken, en dit zou wereldwijd milljoenen mensen treffen (Mabey 2008; WHO 2008). Het 
opvolgen van de verspreiding van Tc
R
 Chlamydia suis binnen de varkenssector en de 
mogelijk zoonotische transmissie naar de mens is noodzakelijk om het geassocieerde risico en 
de nodige maatregelen te kunnen bepalen. Hiervoor zijn betrouwbare, Chlamydia suis-
specifieke moleculaire en serologische testen voor de detectie van Chlamydia suis bacteriën 
en Chlamydia suis-specifieke antistoffen in dierlijke en menselijke specimen vereist. 
Hoofdstuk I geeft een kort overzicht van de geschiedenis, taxonomie en biologie van 
chlamydiale infecties, gevolgd door een korte inleiding over de chlamydiale effector eiwitten 
en het ‘outer membrane complex’. Verder wordt ook het voorkomen van Chlamydiaceae 
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species in varkens beschreven, met de nadruk op diagnose, epidemiologie, pathologie 
antibioticum resistentie en zoonose van Chlamydia suis. 
Hoofdstuk II beschrijft de ontwikkeling van een gevoelige en specifieke TaqMan probe-
gebaseerde Chlamydia suis real-time PCR voor het analyseren van klinische stalen van mens 
en dier. De analytische gevoeligheid van deze real-time PCR is 10 rDNA kopijen/reactie, en 
dit zonder kruis-amplificatie met DNA van andere Chlamydia species. De PCR werd 
succesvol gevalideerd aan de hand van conjuctivale, faryngale en fecale stalen van mensen 
die dagelijks contact hebben met varkens. Bovendien werden ook stalen afkomstig van 
varkens van een gezond bedrijf en twee bedrijven met reproductiestoornissen geanalyseerd.  
Het assay kan aangewend worden voor de detectie van Chlamydia suis stammen in varkens, 
en voor het verder onderzoek naar het zoönotisch potentieel van deze bacterie. Bovendien kan 
deze real-time PCR nuttig zijn voor het opvolgen en het voorkomen van de verspreiding van 
C. suis stammen, onder meer via de internationale sperma handel voor varkens. 
In hoofdstuk III werd de aanwezigheid onderzocht van C.  suis in een varkensslachthuis, 
meer bepaald in varkens, ter hoogte van contact oppervlakken, in de lucht en in de 
werknemers. Hierbij werd gebruik gemaakt van Chlamydia isolatie in celcultuur en the real-
time PCR ontwikkeld in hoofdstuk II. Bovendien werden de geïdentificeerde C. suis isolaten 
getest op de aanwezigheid van het tet(C) gen. De aanwezigheid van C. suis bacteriën kon 
aangetoond worden in stalen afkomstig van varkens, de lucht en verschillende 
contactoppervlakken verspreid in het slachthuis. Bovedien testten ook oogstalen afkomstig 
van twee werknemers positief in zowel isolatie als PCR. Het tet(C) gen kon niet aangetoond 
worden in de menselijke C. suis isolaten. De werknemers vertoonden ook geen klinische 
symptomen en waren negatief voor C. trachomatis. Echter, het verwerven van het tet(C) gen 
door C. suis, voornamelijk bij blootstelling aan een selectieve druk, en de potentiële transfer 
van C. suis naar de mens, zou vergaande gevolgen kunnen hebben voor de volksgezondheid. 
Deze bevindingen benadrukken de nood voor verder onderzoek om de rol en betekenis van 
oculaire C. suis infecties bij de mens te verduidelijken.  
In hoodstuk IV werden antigene en C. suis specifieke peptide geïdentificeerd die aangewend 
kunnen worden voor serodiagnose. De aminozuursequenties van drie kandidaat eiwitten van 
de Chlamydia species die voorkomen bij varkens en de mens werden gealigneerd, voor de 
selectie van Chlamydia suis specifieke peptiden. Sequentie alignering en software-gebaseerde 
analyse van de antigeniciteit werden gecombineerd met de in vitro screening met behulp van 
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een set van controle sera afkomstig van varkens. Daarnaast werd ook een set van moleculair 
gekarakteriseerde veldsera gebruikt om de bruikbaarheid van de PeptideA en B antigenen 
voor serodiagnose van C. suis, te bevestigen. Hierbij bleek het PeptideA gevoeliger dan 
PeptideB. Hoewel verdere optimalisatie van het assay en specificiteitsanalyse van de 
antigenen met C. trachomatis antisera vereist zijn, is het geïdentificeerde PeptideA ook een 
veelbelovende kandidaat voor de ontwikkeling van een C. suis serodiagnose assay voor de 
mens. 
In hoofdstuk V werden ten slotte onze conclusies en toekomstperspectieven voor verder 
onderzoek beschreven. 
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